PPARG Human (+)-(S)-ar-turmerone affects binding EXP 6480464 ar-turmerone binds to PPARG protein CTD PMID:15713005 PPARG Human (+)-catechin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Catechin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] CTD PMID:23365609 PPARG Human (+)-schisandrin B multiple interactions ISO Pparg (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PPARG mRNA] CTD PMID:31150632 PPARG Human (-)-citrinin decreases activity EXP 6480464 Citrinin results in decreased activity of PPARG protein CTD PMID:27481073 PPARG Human (-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of PPARG mRNA CTD PMID:20706672 PPARG Human (-)-quinic acid multiple interactions ISO Pparg (Mus musculus) 6480464 Quinic Acid inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] CTD PMID:36006763 PPARG Human (1->4)-beta-D-glucan multiple interactions ISO Pparg (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PPARG mRNA CTD PMID:36331819 PPARG Human (20S)-ginsenoside Rh1 multiple interactions ISO Pparg (Mus musculus) 6480464 ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] and ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG protein] CTD PMID:32623698 PPARG Human (25R)-cholest-5-ene-3beta,26-diol increases expression ISO Pparg (Rattus norvegicus) 6480464 27-hydroxycholesterol results in increased expression of PPARG mRNA and 27-hydroxycholesterol results in increased expression of PPARG protein CTD PMID:28167099 PPARG Human (3-phenoxyphenyl)methanol multiple interactions ISO Pparg (Mus musculus) 6480464 3-phenoxybenzylalcohol binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human (3-phenoxyphenyl)methanol multiple interactions EXP 6480464 3-phenoxybenzylalcohol binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosahexaenoic acid multiple interactions ISO Pparg (Mus musculus) 6480464 17-hydroxy-4 more ... CTD PMID:17056761 PPARG Human (9E,11E)-octadecadienoic acid affects binding EXP 6480464 9 and 11-linoleic acid binds to PPARG protein CTD PMID:23843199 PPARG Human (9E,11E)-octadecadienoic acid increases activity EXP 6480464 9 and 11-linoleic acid results in increased activity of PPARG protein CTD PMID:18155510 PPARG Human (R)-carnitine multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Carnitine inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein] CTD PMID:30256492 PPARG Human (R)-carnitine increases expression ISO Pparg (Rattus norvegicus) 6480464 Carnitine results in increased expression of PPARG protein CTD PMID:30256492 PPARG Human (R)-lipoic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA CTD PMID:22464149 PPARG Human (R)-noradrenaline increases expression ISO Pparg (Rattus norvegicus) 6480464 Norepinephrine results in increased expression of PPARG mRNA CTD PMID:19109942 PPARG Human (R,R,R)-alpha-tocopherol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA] and [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 PPARG Human (R,R,R)-alpha-tocopherol increases expression ISO Pparg (Rattus norvegicus) 6480464 alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:11752099 PPARG Human (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of PPARG mRNA and alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:14521714 and PMID:28062356 PPARG Human (R,R,R)-alpha-tocopherol increases activity EXP 6480464 alpha-Tocopherol results in increased activity of PPARG protein CTD PMID:19083475 PPARG Human (S)-naringenin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:29223569 and PMID:31063766 PPARG Human (S)-naringenin multiple interactions ISO Pparg (Mus musculus) 6480464 naringenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARG protein] CTD PMID:31063766 PPARG Human (S)-nicotine decreases expression ISO Pparg (Mus musculus) 6480464 Nicotine results in decreased expression of PPARG protein CTD PMID:33082140 PPARG Human (S)-nicotine increases expression ISO Pparg (Mus musculus) 6480464 Nicotine results in increased expression of PPARG mRNA CTD PMID:31622651 PPARG Human (Z)-ligustilide multiple interactions ISO Pparg (Mus musculus) 6480464 ligustilide inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein] more ... CTD PMID:33130971 PPARG Human 1,1-dichloroethene increases expression ISO Pparg (Mus musculus) 6480464 vinylidene chloride results in increased expression of PPARG mRNA CTD PMID:26682919 PPARG Human 1,2-dimethylhydrazine decreases expression ISO Pparg (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of PPARG mRNA CTD PMID:22206623 PPARG Human 1,2-dimethylhydrazine multiple interactions ISO Pparg (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA CTD PMID:22206623 PPARG Human 1,3-thiazolidine-2,4-dione increases expression ISO Pparg (Rattus norvegicus) 6480464 2 and 4-thiazolidinedione results in increased expression of PPARG mRNA CTD PMID:20724125 PPARG Human 1,3-thiazolidine-2,4-dione affects binding EXP 6480464 2 and 4-thiazolidinedione binds to PPARG protein CTD PMID:15916743 PPARG Human 1,3-thiazolidine-2,4-dione multiple interactions EXP 6480464 2 and 4-thiazolidinedione binds to and results in increased activity of PPARG protein CTD PMID:15521013 PPARG Human 1,4-bis(2-ethylhexyl) sulfosuccinate increases activity ISO Pparg (Mus musculus) 6480464 Dioctyl Sulfosuccinic Acid results in increased activity of PPARG protein CTD PMID:26135921 PPARG Human 1,4-bis(2-ethylhexyl) sulfosuccinate multiple interactions EXP 6480464 Dioctyl Sulfosuccinic Acid binds to and results in increased activity of PPARG protein CTD PMID:26135921 PPARG Human 1,4-phenylenediamine increases expression EXP 6480464 4-phenylenediamine results in increased expression of PPARG mRNA CTD PMID:16314067 PPARG Human 1-Hydroxypyrene multiple interactions EXP 6480464 1-hydroxypyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 1-Hydroxypyrene multiple interactions ISO Pparg (Mus musculus) 6480464 1-hydroxypyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 1-naphthyl isothiocyanate decreases expression ISO Pparg (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in decreased expression of PPARG mRNA CTD PMID:30723492 PPARG Human 10H-phenothiazine multiple interactions ISO Pparg (Mus musculus) 6480464 phenothiazine binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 10H-phenothiazine multiple interactions EXP 6480464 phenothiazine binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 13-HPODE increases expression ISO Pparg (Rattus norvegicus) 6480464 13-hydroperoxy-9 and 11-octadecadienoic acid results in increased expression of PPARG protein CTD PMID:22135674 PPARG Human 14-Deoxy-11,12-didehydroandrographolide multiple interactions ISO Pparg (Mus musculus) 6480464 14-deoxy-11 more ... CTD PMID:30248417 PPARG Human 15-acetyldeoxynivalenol decreases activity EXP 6480464 15-acetyldeoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 PPARG Human 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:11030710 more ... PPARG Human 15-deoxy-Delta(12,14)-prostaglandin J2 increases activity EXP 6480464 15-deoxy-delta(12 and 14)-prostaglandin J2 results in increased activity of PPARG protein CTD PMID:15707588 more ... PPARG Human 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression EXP 6480464 15-deoxy-delta(12 and 14)-prostaglandin J2 results in decreased expression of PPARG protein CTD PMID:17341418 PPARG Human 15-deoxy-Delta(12,14)-prostaglandin J2 affects expression EXP 6480464 15-deoxy-delta(12 and 14)-prostaglandin J2 affects the expression of PPARG CTD PMID:15254749 PPARG Human 15-deoxy-Delta(12,14)-prostaglandin J2 decreases response to substance EXP 6480464 PPARG protein mutant form results in decreased susceptibility to 15-deoxy-delta(12 and 14)-prostaglandin J2 CTD PMID:19922793 PPARG Human 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO Pparg (Rattus norvegicus) 6480464 15-deoxy-delta(12 more ... CTD PMID:10662598 more ... PPARG Human 15-deoxy-Delta(12,14)-prostaglandin J2 increases activity ISO Pparg (Mus musculus) 6480464 15-deoxy-delta(12 and 14)-prostaglandin J2 results in increased activity of PPARG protein CTD PMID:15322177 PPARG Human 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO Pparg (Rattus norvegicus) 6480464 15-deoxy-delta(12 more ... CTD PMID:15994020 and PMID:18278065 PPARG Human 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO Pparg (Mus musculus) 6480464 15-deoxy-delta(12 more ... CTD PMID:12847270 and PMID:16324150 PPARG Human 17alpha-ethynylestradiol increases expression ISO Pparg (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of PPARG mRNA CTD PMID:29112739 PPARG Human 17alpha-ethynylestradiol multiple interactions ISO Pparg (Mus musculus) 6480464 ESR1 gene mutant form inhibits the reaction [Ethinyl Estradiol results in increased expression of PPARG mRNA] CTD PMID:29112739 PPARG Human 17beta-estradiol multiple interactions EXP 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]] more ... CTD PMID:19619570 more ... PPARG Human 17beta-estradiol affects expression ISO Pparg (Rattus norvegicus) 6480464 Estradiol affects the expression of PPARG mRNA and Estradiol affects the expression of PPARG protein CTD PMID:22389237 PPARG Human 17beta-estradiol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA] and [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 PPARG Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of PPARG mRNA CTD PMID:19619570 more ... PPARG Human 17beta-estradiol increases expression ISO Pparg (Mus musculus) 6480464 Estradiol results in increased expression of PPARG mRNA CTD PMID:18359623 PPARG Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PPARG mRNA CTD PMID:21632903 more ... PPARG Human 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of PPARG mRNA and Dihydrotestosterone results in decreased expression of PPARG protein CTD PMID:18801408 PPARG Human 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO Pparg (Mus musculus) 6480464 Dihydrotestosterone results in increased expression of PPARG mRNA CTD PMID:16990341 PPARG Human 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO Pparg (Mus musculus) 6480464 Dihydrotestosterone results in decreased expression of PPARG mRNA and Dihydrotestosterone results in decreased expression of PPARG protein CTD PMID:12960001 PPARG Human 1H-pyrazole increases expression ISO Pparg (Mus musculus) 6480464 pyrazole results in increased expression of PPARG mRNA CTD PMID:17945193 PPARG Human 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:31449830 PPARG Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Pparg (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 and PMID:31449830 PPARG Human 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:29112739 and PMID:29523931 PPARG Human 2,2',4,4'-Tetrabromodiphenyl ether increases activity EXP 6480464 2 more ... CTD PMID:26172262 and PMID:28282128 PPARG Human 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:23398518 PPARG Human 2,2',4,4'-Tetrabromodiphenyl ether decreases methylation ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:24559133 PPARG Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:24559133 more ... PPARG Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:23146750 PPARG Human 2,2',4,4'-Tetrabromodiphenyl ether affects binding EXP 6480464 2 more ... CTD PMID:25314719 PPARG Human 2,2'-Bisphenol F multiple interactions EXP 6480464 2 and 2'-bisphenol F binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 2,2'-Bisphenol F multiple interactions ISO Pparg (Mus musculus) 6480464 2 and 2'-bisphenol F binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 2,2'-Dihydroxy-4-methoxybenzophenone multiple interactions EXP 6480464 dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] and dioxybenzone promotes the reaction [NCOA2 protein binds to PPARG protein] CTD PMID:32407875 PPARG Human 2,2'-Dihydroxy-4-methoxybenzophenone increases expression EXP 6480464 dioxybenzone results in increased expression of PPARG mRNA CTD PMID:32407875 PPARG Human 2,2'-Dihydroxy-4-methoxybenzophenone affects binding EXP 6480464 dioxybenzone binds to PPARG protein CTD PMID:32407875 PPARG Human 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononanoic acid increases expression ISO Pparg (Mus musculus) 6480464 hexadecafluoro-nonanoic acid results in increased expression of PPARG mRNA CTD PMID:18583369 PPARG Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Pparg (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA CTD PMID:24058054 more ... PPARG Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Pparg (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PPARG mRNA CTD PMID:36222588 PPARG Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA CTD PMID:19619570 more ... PPARG Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Pparg (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA and Tetrachlorodibenzodioxin results in decreased expression of PPARG protein CTD PMID:12758056 more ... PPARG Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Pparg (Mus musculus) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] more ... CTD PMID:12758056 more ... PPARG Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA CTD PMID:19619570 PPARG Human 2,4,5-trichlorophenol multiple interactions EXP 6480464 2 more ... CTD PMID:33049310 PPARG Human 2,4,5-trichlorophenol multiple interactions ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:33049310 PPARG Human 2,4,6-tribromophenol affects binding EXP 6480464 2 more ... CTD PMID:25314719 PPARG Human 2,4,6-trichlorophenol affects binding EXP 6480464 2 more ... CTD PMID:25314719 PPARG Human 2,4,6-Trimethylbenzaldehyde multiple interactions EXP 6480464 2 more ... CTD PMID:27633901 PPARG Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA] more ... CTD PMID:16782535 more ... PPARG Human 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO Pparg (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA CTD PMID:21829567 PPARG Human 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO Pparg (Rattus norvegicus) 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA and Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein CTD PMID:16782535 more ... PPARG Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects binding EXP 6480464 2 more ... CTD PMID:25314719 PPARG Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases methylation ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:30903904 PPARG Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:30903904 PPARG Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:30903904 PPARG Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:30903904 PPARG Human 2,4-dinitrotoluene increases expression ISO Pparg (Mus musculus) 6480464 2 and 4-dinitrotoluene results in increased expression of PPARG mRNA CTD PMID:24893713 PPARG Human 2,4-dinitrotoluene increases activity ISO Pparg (Mus musculus) 6480464 2 and 4-dinitrotoluene results in increased activity of PPARG protein CTD PMID:24893713 PPARG Human 2,5-di-tert-butylbenzene-1,4-diol multiple interactions EXP 6480464 2 and 5-di-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 2,5-di-tert-butylbenzene-1,4-diol multiple interactions ISO Pparg (Mus musculus) 6480464 2 and 5-di-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 2,6-di-tert-butyl-4-methylphenol increases expression ISO Pparg (Mus musculus) 6480464 Butylated Hydroxytoluene results in increased expression of PPARG mRNA CTD PMID:19925653 PPARG Human 2,6-di-tert-butyl-4-methylphenol multiple interactions EXP 6480464 Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of PPARG mRNA] CTD PMID:17070507 PPARG Human 2,6-diisopropylnaphthalene multiple interactions EXP 6480464 2 and 6-diisopropylnaphthalene binds to and results in increased activity of PPARG protein CTD PMID:27633901 PPARG Human 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO Pparg (Mus musculus) 6480464 [lipopolysaccharide more ... CTD PMID:30236599 and PMID:30550845 PPARG Human 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 PPARG Human 2-amino-2-deoxy-D-glucopyranose increases expression ISO Pparg (Rattus norvegicus) 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 PPARG Human 2-amino-2-deoxy-D-glucopyranose increases expression ISO Pparg (Mus musculus) 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 PPARG Human 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 PPARG Human 2-amino-2-deoxy-D-glucopyranose 6-phosphate decreases expression ISO Pparg (Mus musculus) 6480464 glucosamine 6-phosphate results in decreased expression of PPARG protein CTD PMID:19427183 PPARG Human 2-arachidonoylglycerol affects binding EXP 6480464 glyceryl 2-arachidonate metabolite binds to PPARG protein CTD PMID:21511917 PPARG Human 2-arachidonoylglycerol multiple interactions ISO Pparg (Mus musculus) 6480464 glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein] more ... CTD PMID:26209559 PPARG Human 2-arachidonoylglycerol multiple interactions EXP 6480464 T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA] CTD PMID:21511917 PPARG Human 2-arachidonoylglycerol increases expression EXP 6480464 glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA CTD PMID:21511917 PPARG Human 2-benzyl-4-chlorophenol multiple interactions EXP 6480464 clorophene binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 2-benzyl-4-chlorophenol multiple interactions ISO Pparg (Mus musculus) 6480464 clorophene binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 2-bromohexadecanoic acid increases expression ISO Pparg (Rattus norvegicus) 6480464 2-bromopalmitate results in increased expression of PPARG protein CTD PMID:10650946 PPARG Human 2-deoxy-D-glucose affects uptake ISO Pparg (Mus musculus) 6480464 PPARG protein affects the uptake of Deoxyglucose CTD PMID:18083318 PPARG Human 2-deoxy-D-glucose increases uptake ISO Pparg (Mus musculus) 6480464 PPARG gene polymorphism results in increased uptake of Deoxyglucose CTD PMID:18083318 PPARG Human 2-Ethylhexanoic acid increases expression ISO Pparg (Rattus norvegicus) 6480464 2-ethylhexanoic acid results in increased expression of PPARG mRNA and 2-ethylhexanoic acid results in increased expression of PPARG protein CTD PMID:15647598 PPARG Human 2-Ethylhexyl acrylate multiple interactions EXP 6480464 2-ethylhexyl acrylate binds to and results in increased activity of PPARG protein CTD PMID:27633901 PPARG Human 2-palmitoylglycerol increases expression EXP 6480464 2-palmitoylglycerol results in increased expression of PPARG mRNA CTD PMID:37199045 PPARG Human 2-tert-butylhydroquinone multiple interactions ISO Pparg (Mus musculus) 6480464 2-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 2-tert-butylhydroquinone multiple interactions EXP 6480464 2-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO Pparg (Rattus norvegicus) 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] CTD PMID:20578043 PPARG Human 25-hydroxycholesterol multiple interactions EXP 6480464 [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA] and [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol] CTD PMID:12595494 PPARG Human 26-hydroxycholesterol increases expression ISO Pparg (Rattus norvegicus) 6480464 27-hydroxycholesterol results in increased expression of PPARG mRNA and 27-hydroxycholesterol results in increased expression of PPARG protein CTD PMID:28167099 PPARG Human 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO Pparg (Rattus norvegicus) 6480464 pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein] CTD PMID:16598202 PPARG Human 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO Pparg (Rattus norvegicus) 6480464 Puromycin Aminonucleoside results in increased expression of PPARG protein CTD PMID:16598202 PPARG Human 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [3 more ... CTD PMID:25304490 PPARG Human 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Pparg (Mus musculus) 6480464 3 more ... CTD PMID:28973532 PPARG Human 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:25304490 and PMID:35618242 PPARG Human 3,3',4,4'-tetrachlorobiphenyl increases expression ISO Pparg (Mus musculus) 6480464 3 more ... CTD PMID:30935970 PPARG Human 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of PPARG mRNA CTD PMID:32473317 PPARG Human 3,3',5,5'-tetrabromobisphenol A increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to tetrabromobisphenol A CTD PMID:35734227 PPARG Human 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO Pparg (Rattus norvegicus) 6480464 tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA] CTD PMID:25048947 PPARG Human 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Pparg (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of PPARG protein CTD PMID:24132472 PPARG Human 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO Pparg (Mus musculus) 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [tetrabromobisphenol A results in decreased expression of PPARG protein] more ... CTD PMID:24132472 more ... PPARG Human 3,3',5,5'-tetrabromobisphenol A affects binding EXP 6480464 tetrabromobisphenol A binds to PPARG protein CTD PMID:25314719 PPARG Human 3,3',5,5'-tetrabromobisphenol A increases expression ISO Pparg (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of PPARG mRNA CTD PMID:25863188 and PMID:30496566 PPARG Human 3,3',5,5'-tetrabromobisphenol A increases activity ISO Pparg (Mus musculus) 6480464 tetrabromobisphenol A results in increased activity of PPARG protein CTD PMID:25777084 more ... PPARG Human 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Pparg (Rattus norvegicus) 6480464 tetrabromobisphenol A results in decreased expression of PPARG mRNA CTD PMID:26988606 PPARG Human 3,3',5,5'-tetrabromobisphenol A increases activity EXP 6480464 tetrabromobisphenol A results in increased activity of PPARG protein CTD PMID:24591153 more ... PPARG Human 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP 6480464 [PPARG protein results in increased susceptibility to tetrabromobisphenol A] which results in decreased expression of DHRS2 mRNA more ... CTD PMID:21561829 more ... PPARG Human 3,3',5,5'-tetraiodothyroacetic acid multiple interactions ISO Pparg (Mus musculus) 6480464 tetraiodothyroacetic acid binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 3,3',5,5'-tetraiodothyroacetic acid multiple interactions EXP 6480464 tetraiodothyroacetic acid binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 3,3',5-triiodo-L-thyronine multiple interactions ISO Pparg (Mus musculus) 6480464 Triiodothyronine binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 3,3',5-triiodo-L-thyronine multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Triiodothyronine inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA] CTD PMID:25048947 PPARG Human 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA more ... CTD PMID:33049310 and PMID:33476690 PPARG Human 3,3'-Dimethylbenzidine multiple interactions ISO Pparg (Mus musculus) 6480464 2-tolidine binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 3,3'-Dimethylbenzidine multiple interactions EXP 6480464 2-tolidine binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 3,4-Dimethylbenzaldehyde multiple interactions EXP 6480464 3 and 4-dimethylbenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 PPARG Human 3,5,6-trichloro-2-pyridinol multiple interactions ISO Pparg (Mus musculus) 6480464 3 more ... CTD PMID:32017950 PPARG Human 3,5,6-trichloropyridine-2-one multiple interactions ISO Pparg (Mus musculus) 6480464 3 more ... CTD PMID:32017950 PPARG Human 3,5-di-tert-Butyl-4-hydroxybenzaldehyde multiple interactions EXP 6480464 3 and 5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 PPARG Human 3,6-diaminoacridine multiple interactions EXP 6480464 Proflavine inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 PPARG Human 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid increases activity EXP 6480464 MK-886 results in increased activity of PPARG protein CTD PMID:15899809 PPARG Human 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid increases expression EXP 6480464 MK-886 results in increased expression of PPARG mRNA CTD PMID:15899809 PPARG Human 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid affects localization EXP 6480464 MK-886 affects the localization of PPARG protein CTD PMID:15899809 PPARG Human 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions EXP 6480464 [Indomethacin co-treated with MK-886] affects the localization of PPARG protein and Indomethacin promotes the reaction [MK-886 results in increased activity of PPARG protein] CTD PMID:15899809 PPARG Human 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] CTD PMID:16945329 PPARG Human 3-acetyldeoxynivalenol decreases activity EXP 6480464 3-acetyldeoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 PPARG Human 3-aminobenzamide multiple interactions ISO Pparg (Rattus norvegicus) 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 PPARG Human 3-aminobenzamide decreases ADP-ribosylation ISO Pparg (Rattus norvegicus) 6480464 3-aminobenzamide results in decreased ADP-ribosylation of PPARG protein CTD PMID:18815186 PPARG Human 3-aminobenzamide increases activity ISO Pparg (Rattus norvegicus) 6480464 3-aminobenzamide results in increased activity of PPARG protein CTD PMID:18815186 PPARG Human 3-iodoprop-2-yn-1-yl butylcarbamate multiple interactions EXP 6480464 3-iodo-2-propynylbutylcarbamate binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 3-iodoprop-2-yn-1-yl butylcarbamate multiple interactions ISO Pparg (Mus musculus) 6480464 3-iodo-2-propynylbutylcarbamate binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Pparg (Mus musculus) 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein] more ... CTD PMID:11101056 more ... PPARG Human 3-isobutyl-1-methyl-7H-xanthine increases expression EXP 6480464 1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA CTD PMID:22645054 PPARG Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA CTD PMID:21350315 PPARG Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Firemaster 550] results in increased expression of PPARG mRNA more ... CTD PMID:19186324 more ... PPARG Human 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one multiple interactions EXP 6480464 alpha-isomethylionone binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one multiple interactions ISO Pparg (Mus musculus) 6480464 alpha-isomethylionone binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 3-methylglutaric acid increases expression ISO Pparg (Rattus norvegicus) 6480464 3-methylglutaric acid results in increased expression of PPARG protein CTD PMID:32169667 PPARG Human 3-methylglutaric acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Bezafibrate inhibits the reaction [3-methylglutaric acid results in increased expression of PPARG protein] CTD PMID:32169667 PPARG Human 3-phenylprop-2-enal decreases expression ISO Pparg (Mus musculus) 6480464 cinnamaldehyde results in decreased expression of PPARG mRNA CTD PMID:21401097 PPARG Human 4'-Methoxychalcone multiple interactions ISO Pparg (Mus musculus) 6480464 4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA] and 4'-methoxychalcone analog results in increased expression of and results in increased activity of PPARG protein CTD PMID:28528971 PPARG Human 4'-Methoxychalcone increases expression ISO Pparg (Mus musculus) 6480464 4'-methoxychalcone analog results in increased expression of PPARG mRNA CTD PMID:28528971 PPARG Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of PPARG mRNA and bisphenol S results in increased expression of PPARG protein CTD PMID:27003841 more ... PPARG Human 4,4'-sulfonyldiphenol increases expression ISO Pparg (Mus musculus) 6480464 bisphenol S results in increased expression of PPARG mRNA CTD PMID:30951980 and PMID:30959087 PPARG Human 4,4'-sulfonyldiphenol increases activity EXP 6480464 bisphenol S analog results in increased activity of PPARG protein and bisphenol S results in increased activity of PPARG protein CTD PMID:29331639 PPARG Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PPARG mRNA more ... CTD PMID:27633901 more ... PPARG Human 4,4'-sulfonyldiphenol increases activity ISO Pparg (Mus musculus) 6480464 bisphenol S results in increased activity of PPARG protein CTD PMID:27273607 PPARG Human 4,4'-sulfonyldiphenol multiple interactions ISO Pparg (Mus musculus) 6480464 [bisphenol S co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:27241191 more ... PPARG Human 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO Pparg (Mus musculus) 6480464 Oxazolone results in increased expression of PPARG protein CTD PMID:22200888 PPARG Human 4-(ethoxymethylene)-2-phenyloxazol-5-one multiple interactions ISO Pparg (Mus musculus) 6480464 tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein] CTD PMID:22200888 PPARG Human 4-chloro-3,5-dimethylphenol multiple interactions EXP 6480464 chloroxylenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 4-chloro-3,5-dimethylphenol multiple interactions ISO Pparg (Mus musculus) 6480464 chloroxylenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of PPARG protein CTD PMID:27417252 PPARG Human 4-hydroxyphenyl retinamide decreases expression ISO Pparg (Mus musculus) 6480464 Fenretinide results in decreased expression of PPARG mRNA CTD PMID:28973697 PPARG Human 4-hydroxyphenyl retinamide increases activity EXP 6480464 Fenretinide results in increased activity of PPARG protein CTD PMID:16274795 PPARG Human 4-Methyl-3-penten-2-one, 9CI multiple interactions EXP 6480464 mesityl oxide binds to and results in decreased activity of PPARG protein CTD PMID:33049310 PPARG Human 4-nonylphenol increases expression ISO Pparg (Rattus norvegicus) 6480464 4-nonylphenol results in increased expression of PPARG mRNA CTD PMID:24388992 PPARG Human 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] CTD PMID:36670177 PPARG Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of PPARG mRNA CTD PMID:16763620 PPARG Human 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of PPARG mRNA CTD PMID:23300844 PPARG Human 5-azacytidine decreases methylation ISO Pparg (Mus musculus) 6480464 Azacitidine results in decreased methylation of PPARG promoter CTD PMID:19589179 PPARG Human 5-azacytidine increases expression ISO Pparg (Mus musculus) 6480464 Azacitidine results in increased expression of PPARG mRNA CTD PMID:19589179 PPARG Human 5-fluorouracil decreases expression EXP 6480464 Fluorouracil results in decreased expression of PPARG protein CTD PMID:15352031 PPARG Human 5-fluorouracil affects response to substance EXP 6480464 PPARG protein affects the susceptibility to Fluorouracil CTD PMID:15352031 PPARG Human 5-formyltetrahydrofolic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of PPARG mRNA and [Methotrexate co-treated with Leucovorin] results in increased expression of PPARG protein CTD PMID:25187349 PPARG Human 6-propyl-2-thiouracil decreases expression ISO Pparg (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of PPARG mRNA CTD PMID:24780913 PPARG Human 6alpha-methylprednisolone multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:37659742 PPARG Human 6alpha-methylprednisolone increases expression ISO Pparg (Rattus norvegicus) 6480464 Methylprednisolone results in increased expression of PPARG mRNA and Methylprednisolone results in increased expression of PPARG protein CTD PMID:37659742 PPARG Human 7,12-dimethyltetraphene multiple interactions ISO Pparg (Mus musculus) 6480464 9 more ... CTD PMID:33049310 PPARG Human 7,12-dimethyltetraphene multiple interactions EXP 6480464 9 more ... CTD PMID:33049310 PPARG Human 8-(4-chlorophenylthio)-cGMP multiple interactions ISO Pparg (Mus musculus) 6480464 8-(4-chlorophenylthio)guanosine 3' more ... CTD PMID:20471953 PPARG Human 8-(4-chlorophenylthio)-cGMP increases expression ISO Pparg (Mus musculus) 6480464 8-((4-chlorophenyl)thio)cyclic-3' and 5'-GMP results in increased expression of PPARG protein CTD PMID:20471953 PPARG Human 8-Br-cAMP decreases expression ISO Pparg (Rattus norvegicus) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARG mRNA CTD PMID:15994020 PPARG Human 8-Br-cAMP multiple interactions ISO Pparg (Rattus norvegicus) 6480464 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA] CTD PMID:15994020 PPARG Human 9,10-epoxy-12-octadecenoic acid affects binding ISO Pparg (Mus musculus) 6480464 9 and 10-epoxy-12-octadecenoic acid binds to PPARG protein CTD PMID:12021203 PPARG Human 9,11,13-octadecatrienoic acid increases expression EXP 6480464 eleostearic acid results in increased expression of PPARG mRNA and eleostearic acid results in increased expression of PPARG protein CTD PMID:15961301 PPARG Human 9-cis,11-trans-octadecadienoic acid multiple interactions EXP 6480464 2 more ... CTD PMID:36875279 PPARG Human 9-cis-retinoic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter] and Alitretinoin binds to and results in increased activity of PPARG protein CTD PMID:15150131 and PMID:18063688 PPARG Human 9-cis-retinoic acid increases activity EXP 6480464 Alitretinoin results in increased activity of PPARG protein CTD PMID:15707588 PPARG Human 9-cis-retinoic acid multiple interactions ISO Pparg (Mus musculus) 6480464 [Pioglitazone co-treated with Alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine] and PPARG protein promotes the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA] CTD PMID:16513826 and PMID:17019405 PPARG Human 9-cis-retinoic acid multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Alitretinoin results in increased activity of PPARG protein] and MG 262 promotes the reaction [Alitretinoin results in increased activity of PPARG protein] CTD PMID:15707588 PPARG Human 9-HODE increases expression EXP 6480464 9-hydroxy-10 and 12-octadecadienoic acid results in increased expression of PPARG CTD PMID:16647253 PPARG Human 9-phenanthrol multiple interactions ISO Pparg (Mus musculus) 6480464 9-phenanthrol binds to and affects the activity of PPARG protein CTD PMID:33049310 PPARG Human 9-phenanthrol multiple interactions EXP 6480464 9-phenanthrol binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human [6]-Shogaol increases activity ISO Pparg (Mus musculus) 6480464 shogaol results in increased activity of PPARG protein CTD PMID:18577375 PPARG Human AACOCF3 multiple interactions ISO Pparg (Mus musculus) 6480464 arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] CTD PMID:19063610 PPARG Human acetaldehyde multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]] more ... CTD PMID:17030193 PPARG Human acetic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein] CTD PMID:32045587 PPARG Human acetic acid decreases expression ISO Pparg (Rattus norvegicus) 6480464 Acetic Acid results in decreased expression of PPARG protein CTD PMID:32045587 PPARG Human acetochlor multiple interactions ISO Pparg (Mus musculus) 6480464 acetochlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human acetochlor multiple interactions EXP 6480464 acetochlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human acetophenone multiple interactions EXP 6480464 acetophenone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 PPARG Human acetylsalicylic acid decreases activity EXP 6480464 Aspirin results in decreased activity of PPARG protein CTD PMID:15646027 PPARG Human acetylsalicylic acid decreases expression ISO Pparg (Rattus norvegicus) 6480464 Aspirin results in decreased expression of PPARG mRNA CTD PMID:18222077 PPARG Human acetylsalicylic acid increases expression ISO Pparg (Mus musculus) 6480464 Aspirin results in increased expression of PPARG mRNA CTD PMID:19462226 PPARG Human acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of PPARG more ... CTD PMID:18971601 and PMID:19880272 PPARG Human acetylsalicylic acid multiple interactions EXP 6480464 Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein] CTD PMID:16386710 PPARG Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA CTD PMID:32699268 PPARG Human acrolein multiple interactions ISO Pparg (Mus musculus) 6480464 [Acrolein promotes the reaction [DDIT3 protein binds to PPARG promoter]] which results in decreased expression of PPARG protein more ... CTD PMID:34813903 PPARG Human acrolein decreases expression ISO Pparg (Mus musculus) 6480464 Acrolein results in decreased expression of PPARG protein CTD PMID:34813903 PPARG Human acrylamide multiple interactions ISO Pparg (Mus musculus) 6480464 Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA] more ... CTD PMID:30409764 PPARG Human adefovir pivoxil affects activity EXP 6480464 adefovir dipivoxil affects the activity of PPARG protein CTD PMID:25596134 PPARG Human adenine multiple interactions ISO Pparg (Rattus norvegicus) 6480464 pirfenidone inhibits the reaction [Adenine results in decreased expression of PPARG mRNA] CTD PMID:28866419 PPARG Human adenine decreases expression ISO Pparg (Rattus norvegicus) 6480464 Adenine results in decreased expression of PPARG mRNA CTD PMID:28866419 PPARG Human Aescin multiple interactions EXP 6480464 Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PPARG protein] CTD PMID:36905866 PPARG Human Aescin increases expression EXP 6480464 Escin results in increased expression of PPARG protein CTD PMID:36905866 PPARG Human afimoxifene multiple interactions ISO Pparg (Mus musculus) 6480464 afimoxifene binds to and results in increased activity of PPARG protein and PPARG mRNA promotes the reaction [afimoxifene results in decreased expression of CD36 protein] CTD PMID:27358406 and PMID:33049310 PPARG Human afimoxifene multiple interactions EXP 6480464 afimoxifene binds to and results in increased activity of PPARG protein more ... CTD PMID:27358406 and PMID:33049310 PPARG Human aflatoxin B1 increases expression ISO Pparg (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of PPARG mRNA CTD PMID:19770486 PPARG Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of PPARG gene CTD PMID:27153756 PPARG Human AICA ribonucleotide multiple interactions ISO Pparg (Rattus norvegicus) 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 PPARG Human AICA ribonucleotide multiple interactions EXP 6480464 AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein] CTD PMID:27688165 PPARG Human AL 8810 increases expression ISO Pparg (Mus musculus) 6480464 AL 8810 results in increased expression of PPARG mRNA CTD PMID:21236357 PPARG Human aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 PPARG Human aldehydo-D-glucosamine increases expression ISO Pparg (Rattus norvegicus) 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 PPARG Human aldehydo-D-glucosamine increases expression ISO Pparg (Mus musculus) 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 PPARG Human aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 PPARG Human aldehydo-D-glucosamine 6-phosphate decreases expression ISO Pparg (Mus musculus) 6480464 glucosamine 6-phosphate results in decreased expression of PPARG protein CTD PMID:19427183 PPARG Human aldehydo-D-glucose multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 more ... PPARG Human aldehydo-D-glucose decreases expression ISO Pparg (Rattus norvegicus) 6480464 Glucose results in decreased expression of PPARG mRNA and Glucose results in decreased expression of PPARG protein CTD PMID:19609456 and PMID:31063766 PPARG Human aldehydo-D-glucose multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... PPARG Human aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 PPARG Human aldosterone affects abundance ISO Pparg (Mus musculus) 6480464 PPARG protein affects the abundance of Aldosterone CTD PMID:16007095 PPARG Human Alisol B decreases expression EXP 6480464 alisol B results in decreased expression of PPARG mRNA CTD PMID:35745142 PPARG Human Alisol B multiple interactions ISO Pparg (Mus musculus) 6480464 [alisol B co-treated with Dietary Fats co-treated with Carbon Tetrachloride] results in decreased expression of PPARG mRNA and alisol B inhibits the reaction [[Dietary Fats co-treated with Carbon Tetrachloride] results in increased expression of PPARG mRNA] CTD PMID:35745142 PPARG Human Alisol B multiple interactions EXP 6480464 alisol B inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:35745142 PPARG Human all-trans-retinoic acid multiple interactions ISO Pparg (Mus musculus) 6480464 Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA] CTD PMID:32473317 PPARG Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PPARG mRNA CTD PMID:21934132 and PMID:23724009 PPARG Human all-trans-retinoic acid increases expression ISO Pparg (Rattus norvegicus) 6480464 Tretinoin results in increased expression of PPARG mRNA and Tretinoin results in increased expression of PPARG protein CTD PMID:14568882 PPARG Human all-trans-retinoic acid increases expression ISO Pparg (Mus musculus) 6480464 Tretinoin results in increased expression of PPARG mRNA CTD PMID:17198874 PPARG Human all-trans-retinoic acid decreases expression ISO Pparg (Mus musculus) 6480464 Tretinoin results in decreased expression of PPARG mRNA CTD PMID:11237167 PPARG Human all-trans-retinoic acid multiple interactions EXP 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of PPARG mRNA more ... CTD PMID:16982809 more ... PPARG Human all-trans-retinol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Vitamin A inhibits the reaction [Safflower Oil results in increased expression of PPARG mRNA] CTD PMID:15203375 PPARG Human all-trans-retinol increases expression ISO Pparg (Rattus norvegicus) 6480464 Vitamin A results in increased expression of PPARG mRNA CTD PMID:16180333 PPARG Human allethrin increases expression EXP 6480464 Allethrins results in increased expression of PPARG mRNA CTD PMID:32473317 PPARG Human allethrin increases activity EXP 6480464 Allethrins results in increased activity of PPARG protein CTD PMID:20143881 PPARG Human allyl isothiocyanate multiple interactions ISO Pparg (Rattus norvegicus) 6480464 allyl isothiocyanate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG protein] and allyl isothiocyanate inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein] CTD PMID:30927557 PPARG Human Aloe emodin multiple interactions EXP 6480464 aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA] CTD PMID:22645054 PPARG Human alpha-linolenic acid increases expression ISO Pparg (Mus musculus) 6480464 alpha-Linolenic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 PPARG Human alpha-linolenic acid increases activity EXP 6480464 alpha-Linolenic Acid results in increased activity of PPARG protein CTD PMID:20696231 PPARG Human alpha-linolenic acid multiple interactions EXP 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 PPARG Human alpha-linolenic acid multiple interactions ISO Pparg (Mus musculus) 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 PPARG Human alpha-linolenic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 PPARG Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA CTD PMID:32699268 PPARG Human alpha-Zearalanol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA CTD PMID:35163327 PPARG Human amentoflavone multiple interactions EXP 6480464 amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein more ... CTD PMID:34599948 PPARG Human amiodarone multiple interactions EXP 6480464 [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of FADS2 mRNA] more ... CTD PMID:21123845 and PMID:24489787 PPARG Human amiodarone decreases expression EXP 6480464 Amiodarone results in decreased expression of PPARG mRNA CTD PMID:35641671 PPARG Human amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of PPARG mRNA CTD PMID:21123845 PPARG Human ammonium chloride affects expression ISO Pparg (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of PPARG mRNA CTD PMID:16483693 PPARG Human andrographolide multiple interactions ISO Pparg (Mus musculus) 6480464 andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] CTD PMID:27475717 PPARG Human androst-4-ene-3,17-dione multiple interactions ISO Pparg (Mus musculus) 6480464 Androstenedione binds to and results in decreased activity of PPARG protein CTD PMID:33049310 PPARG Human androst-4-ene-3,17-dione multiple interactions EXP 6480464 Androstenedione binds to and results in decreased activity of PPARG protein CTD PMID:33049310 PPARG Human anthra[1,9-cd]pyrazol-6(2H)-one increases expression ISO Pparg (Rattus norvegicus) 6480464 pyrazolanthrone results in increased expression of PPARG mRNA and pyrazolanthrone results in increased expression of PPARG protein CTD PMID:17372590 PPARG Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Pparg (Rattus norvegicus) 6480464 pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein] CTD PMID:28283887 PPARG Human antimony(0) increases expression ISO Pparg (Mus musculus) 6480464 Antimony results in increased expression of PPARG protein CTD PMID:37858840 PPARG Human antimony(0) multiple interactions ISO Pparg (Mus musculus) 6480464 Fulvestrant inhibits the reaction [Antimony results in increased expression of PPARG protein] CTD PMID:37858840 PPARG Human apigenin multiple interactions ISO Pparg (Mus musculus) 6480464 Apigenin binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 and PMID:33049310 PPARG Human apigenin multiple interactions EXP 6480464 Apigenin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human apigenin decreases expression ISO Pparg (Mus musculus) 6480464 Apigenin results in decreased expression of PPARG mRNA CTD PMID:18359623 PPARG Human arachidonic acid decreases expression EXP 6480464 Arachidonic Acid results in decreased expression of PPARG mRNA and Arachidonic Acid results in decreased expression of PPARG protein CTD PMID:11172467 PPARG Human arachidonic acid increases expression ISO Pparg (Rattus norvegicus) 6480464 Arachidonic Acid results in increased expression of PPARG protein CTD PMID:12604186 PPARG Human arachidonic acid multiple interactions ISO Pparg (Mus musculus) 6480464 Arachidonic Acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] CTD PMID:19063610 PPARG Human Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of PPARG mRNA CTD PMID:16934159 PPARG Human Aroclor 1254 multiple interactions ISO Pparg (Mus musculus) 6480464 [Diethylhexyl Phthalate co-treated with Chlorodiphenyl (54% Chlorine)] results in increased expression of PPARG mRNA CTD PMID:23804495 PPARG Human arsane decreases expression EXP 6480464 Arsenic results in decreased expression of PPARG mRNA and Arsenic results in decreased expression of PPARG protein CTD PMID:23108036 and PMID:36989998 PPARG Human arsane affects expression EXP 6480464 Arsenic affects the expression of PPARG mRNA CTD PMID:28793237 PPARG Human arsane multiple interactions EXP 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA more ... CTD PMID:23108036 more ... PPARG Human arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of PPARG mRNA and Arsenic results in decreased expression of PPARG protein CTD PMID:23108036 and PMID:36989998 PPARG Human arsenic atom affects expression EXP 6480464 Arsenic affects the expression of PPARG mRNA CTD PMID:28793237 PPARG Human arsenic atom multiple interactions EXP 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA more ... CTD PMID:23108036 more ... PPARG Human arsenite(3-) increases expression ISO Pparg (Mus musculus) 6480464 arsenite results in increased expression of PPARG mRNA CTD PMID:15868481 PPARG Human arsenous acid decreases response to substance EXP 6480464 PPARG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 PPARG Human arsenous acid decreases expression ISO Pparg (Rattus norvegicus) 6480464 Arsenic Trioxide results in decreased expression of PPARG mRNA CTD PMID:31258454 PPARG Human arsenous acid multiple interactions ISO Pparg (Mus musculus) 6480464 Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein] more ... CTD PMID:15916724 and PMID:30362509 PPARG Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:30362509 PPARG Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of PPARG mRNA and Arsenic Trioxide results in increased expression of PPARG protein CTD PMID:22684020 and PMID:34108876 PPARG Human arsenous acid decreases expression ISO Pparg (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:15916724 and PMID:30362509 PPARG Human arsenous acid multiple interactions EXP 6480464 [Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide more ... CTD PMID:22684020 more ... PPARG Human aspartame multiple interactions ISO Pparg (Mus musculus) 6480464 [Fats and Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA CTD PMID:23783067 PPARG Human atorvastatin calcium multiple interactions ISO Pparg (Mus musculus) 6480464 Atorvastatin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] CTD PMID:36006763 PPARG Human ATP multiple interactions EXP 6480464 FASN protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]] more ... CTD PMID:26670611 PPARG Human ATP decreases abundance EXP 6480464 PPARG protein mutant form results in decreased abundance of Adenosine Triphosphate and PPARG protein results in decreased abundance of Adenosine Triphosphate CTD PMID:26670611 PPARG Human atrazine multiple interactions EXP 6480464 [Atrazine co-treated with Arsenates] results in increased expression of PPARG mRNA CTD PMID:18585445 PPARG Human atrazine increases expression ISO Pparg (Rattus norvegicus) 6480464 Atrazine results in increased expression of PPARG mRNA and Atrazine results in increased expression of PPARG protein CTD PMID:38056589 PPARG Human atrazine increases expression ISO Pparg (Mus musculus) 6480464 Atrazine results in increased expression of PPARG mRNA CTD PMID:36216167 PPARG Human atrazine multiple interactions ISO Pparg (Mus musculus) 6480464 [Lycopene co-treated with Atrazine] results in increased expression of PPARG mRNA and Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA] CTD PMID:24440342 and PMID:36216167 PPARG Human Aurothioglucose multiple interactions ISO Pparg (Mus musculus) 6480464 [Dietary Fats co-treated with Aurothioglucose] results in decreased expression of PPARG protein CTD PMID:21382165 PPARG Human avobenzone multiple interactions EXP 6480464 avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA] and avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:31016361 and PMID:32407875 PPARG Human avobenzone increases expression EXP 6480464 avobenzone results in increased expression of PPARG mRNA CTD PMID:31016361 and PMID:32407875 PPARG Human azinphos-methyl multiple interactions ISO Pparg (Mus musculus) 6480464 Azinphosmethyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human azinphos-methyl multiple interactions EXP 6480464 Azinphosmethyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human baicalein decreases expression ISO Pparg (Mus musculus) 6480464 baicalein results in decreased expression of PPARG protein CTD PMID:24560969 PPARG Human baicalin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein] CTD PMID:24312512 PPARG Human Bardoxolone methyl increases expression ISO Pparg (Mus musculus) 6480464 bardoxolone methyl results in increased expression of PPARG mRNA and bardoxolone methyl results in increased expression of PPARG protein CTD PMID:21289052 PPARG Human Bavachinin increases expression EXP 6480464 bavachinin results in increased expression of PPARG mRNA and bavachinin results in increased expression of PPARG protein CTD PMID:37358659 PPARG Human bazedoxifene multiple interactions ISO Pparg (Mus musculus) 6480464 bazedoxifene affects the reaction [Oxygen deficiency affects the expression of PPARG protein] CTD PMID:28859903 PPARG Human benzbromarone affects expression ISO Pparg (Mus musculus) 6480464 Benzbromarone affects the expression of PPARG mRNA CTD PMID:19048458 PPARG Human benzene increases expression EXP 6480464 Benzene results in increased expression of PPARG mRNA CTD PMID:19162166 PPARG Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PPARG mRNA CTD PMID:20064835 and PMID:30453624 PPARG Human benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of PPARG mRNA CTD PMID:35641671 PPARG Human benzo[a]pyrene decreases expression ISO Pparg (Rattus norvegicus) 6480464 Benzo(a)pyrene results in decreased expression of PPARG protein CTD PMID:34999049 PPARG Human benzo[a]pyrene multiple interactions EXP 6480464 [Soot co-treated with Benzo(a)pyrene] results in decreased activity of PPARG protein CTD PMID:24464499 PPARG Human benzo[a]pyrene multiple interactions ISO Pparg (Mus musculus) 6480464 Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein] more ... CTD PMID:27329536 PPARG Human benzo[a]pyrene increases activity ISO Pparg (Mus musculus) 6480464 Benzo(a)pyrene results in increased activity of PPARG protein CTD PMID:27329536 PPARG Human benzo[a]pyrene increases expression ISO Pparg (Rattus norvegicus) 6480464 Benzo(a)pyrene results in increased expression of PPARG mRNA and Benzo(a)pyrene results in increased expression of PPARG protein CTD PMID:20920559 and PMID:22374506 PPARG Human benzo[a]pyrene increases expression ISO Pparg (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of PPARG mRNA CTD PMID:22228805 PPARG Human benzo[a]pyrene decreases expression ISO Pparg (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of PPARG mRNA CTD PMID:19770486 PPARG Human benzo[a]pyrene multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA more ... CTD PMID:20920559 and PMID:34999049 PPARG Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PPARG mRNA CTD PMID:15735009 PPARG Human benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 PPARG Human benzofurans decreases expression ISO Pparg (Mus musculus) 6480464 Benzofurans results in decreased expression of PPARG mRNA and Benzofurans results in decreased expression of PPARG protein CTD PMID:20863820 PPARG Human Benzyl parahydroxybenzoate increases activity ISO Pparg (Mus musculus) 6480464 benzylparaben results in increased activity of PPARG protein CTD PMID:28527915 PPARG Human Benzyl parahydroxybenzoate increases expression ISO Pparg (Mus musculus) 6480464 benzylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 and PMID:27659731 PPARG Human berberine multiple interactions ISO Pparg (Mus musculus) 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA] more ... CTD PMID:20564506 and PMID:37839514 PPARG Human berberine decreases expression ISO Pparg (Mus musculus) 6480464 Berberine results in decreased expression of PPARG mRNA and Berberine results in decreased expression of PPARG protein CTD PMID:37511356 PPARG Human berberine multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Berberine inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Dietary Carbohydrates] results in decreased expression of PPARG protein] CTD PMID:18338635 PPARG Human berberine increases response to substance EXP 6480464 PPARG mRNA results in increased susceptibility to Berberine CTD PMID:29408570 PPARG Human berberine multiple interactions EXP 6480464 15-deoxyprostaglandin J2 promotes the reaction [Berberine affects the localization of and results in increased activity of PPARG protein] more ... CTD PMID:29408570 PPARG Human berberine increases expression EXP 6480464 Berberine results in increased expression of PPARG mRNA CTD PMID:29408570 PPARG Human berberine decreases expression EXP 6480464 Berberine results in decreased expression of PPARG mRNA CTD PMID:26478571 PPARG Human Bergenin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 bergenin inhibits the reaction [Iron-Dextran Complex results in decreased expression of PPARG protein] CTD PMID:36207002 PPARG Human Bergenin multiple interactions EXP 6480464 bergenin inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] and PPARG protein promotes the reaction [bergenin inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]] CTD PMID:34499403 PPARG Human beta-carotene decreases expression ISO Pparg (Mus musculus) 6480464 beta Carotene results in decreased expression of PPARG mRNA CTD PMID:21569430 PPARG Human beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 PPARG Human beta-D-glucosamine increases expression ISO Pparg (Rattus norvegicus) 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 PPARG Human beta-D-glucosamine increases expression ISO Pparg (Mus musculus) 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 PPARG Human beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 PPARG Human beta-D-glucosamine 6-sulfate decreases expression ISO Pparg (Mus musculus) 6480464 glucosamine 6-O-sulfate results in decreased expression of PPARG mRNA and glucosamine 6-O-sulfate results in decreased expression of PPARG protein CTD PMID:19520133 PPARG Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of PPARG mRNA CTD PMID:38218311 PPARG Human beta-naphthoflavone multiple interactions ISO Pparg (Mus musculus) 6480464 beta-Naphthoflavone inhibits the reaction [Triclosan results in increased expression of PPARG protein] CTD PMID:33722737 PPARG Human beta-tocopherol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA] and [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 PPARG Human bezafibrate multiple interactions ISO Pparg (Mus musculus) 6480464 PPARA protein affects the reaction [Bezafibrate results in increased expression of PPARG mRNA] CTD PMID:21324916 PPARG Human bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of PPARG mRNA CTD PMID:19201410 and PMID:24759758 PPARG Human bezafibrate affects binding EXP 6480464 Bezafibrate binds to PPARG protein CTD PMID:11779144 and PMID:23843199 PPARG Human bezafibrate increases expression ISO Pparg (Mus musculus) 6480464 Bezafibrate results in increased expression of PPARG mRNA CTD PMID:19201410 and PMID:21324916 PPARG Human bezafibrate increases activity ISO Pparg (Mus musculus) 6480464 Bezafibrate results in increased activity of PPARG protein CTD PMID:12401884 PPARG Human bezafibrate decreases expression EXP 6480464 Bezafibrate results in decreased expression of PPARG mRNA CTD PMID:15708366 PPARG Human bezafibrate multiple interactions EXP 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]] more ... CTD PMID:11779144 and PMID:21734263 PPARG Human bezafibrate multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Bezafibrate inhibits the reaction [3-methylglutaric acid results in increased expression of PPARG protein] and Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA] CTD PMID:12967931 and PMID:32169667 PPARG Human bezafibrate decreases expression ISO Pparg (Rattus norvegicus) 6480464 Bezafibrate results in decreased expression of PPARG mRNA CTD PMID:11473052 PPARG Human bicalutamide multiple interactions ISO Pparg (Mus musculus) 6480464 bicalutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human bicalutamide multiple interactions EXP 6480464 bicalutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human bifenthrin multiple interactions ISO Pparg (Mus musculus) 6480464 bifenthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human bifenthrin increases expression EXP 6480464 bifenthrin results in increased expression of PPARG mRNA CTD PMID:29554630 PPARG Human bifenthrin multiple interactions EXP 6480464 bifenthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human biochanin A multiple interactions ISO Pparg (Mus musculus) 6480464 biochanin A binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human biphenyl-4-ol multiple interactions ISO Pparg (Mus musculus) 6480464 4-phenylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human biphenyl-4-ol multiple interactions EXP 6480464 4-phenylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human bis(2-ethylhexyl) phthalate multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA more ... CTD PMID:20920559 and PMID:28532275 PPARG Human bis(2-ethylhexyl) phthalate decreases expression ISO Pparg (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of PPARG mRNA and Diethylhexyl Phthalate results in decreased expression of PPARG protein CTD PMID:29669060 and PMID:31211961 PPARG Human bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PPARG protein] more ... CTD PMID:27633901 more ... PPARG Human bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA and Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:28025108 more ... PPARG Human bis(2-ethylhexyl) phthalate affects binding EXP 6480464 Diethylhexyl Phthalate binds to PPARG protein and Diethylhexyl Phthalate metabolite binds to PPARG protein CTD PMID:23843199 more ... PPARG Human bis(2-ethylhexyl) phthalate affects expression ISO Pparg (Mus musculus) 6480464 Diethylhexyl Phthalate affects the expression of PPARG mRNA and Diethylhexyl Phthalate affects the expression of PPARG protein CTD PMID:22588786 more ... PPARG Human bis(2-ethylhexyl) phthalate increases expression ISO Pparg (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA and Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:15647598 more ... PPARG Human bis(2-ethylhexyl) phthalate increases expression ISO Pparg (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA and Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:21856391 more ... PPARG Human bis(2-ethylhexyl) phthalate multiple interactions ISO Pparg (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:22197818 more ... PPARG Human bis(2-ethylhexyl) phthalate decreases expression ISO Pparg (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in decreased expression of PPARG protein CTD PMID:16690193 and PMID:29669060 PPARG Human bisdemethoxycurcumin affects binding EXP 6480464 bisdemethoxycurcumin binds to PPARG protein CTD PMID:15713005 PPARG Human bismuth atom multiple interactions EXP 6480464 [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA CTD PMID:34560244 PPARG Human bismuthane multiple interactions EXP 6480464 [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA CTD PMID:34560244 PPARG Human bisphenol A increases localization EXP 6480464 bisphenol A results in increased localization of PPARG protein CTD PMID:20064783 PPARG Human bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of PPARG gene CTD PMID:31601247 PPARG Human bisphenol A decreases methylation ISO Pparg (Mus musculus) 6480464 bisphenol A results in decreased methylation of PPARG promoter CTD PMID:33203037 PPARG Human bisphenol A decreases methylation ISO Pparg (Rattus norvegicus) 6480464 bisphenol A results in decreased methylation of PPARG gene CTD PMID:32701268 PPARG Human bisphenol A decreases expression ISO Pparg (Mus musculus) 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:30133442 and PMID:34199136 PPARG Human bisphenol A affects expression ISO Pparg (Mus musculus) 6480464 bisphenol A affects the expression of PPARG protein CTD PMID:31319301 PPARG Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:28711546 PPARG Human bisphenol A increases activity ISO Pparg (Mus musculus) 6480464 bisphenol A results in increased activity of PPARG protein CTD PMID:27273607 PPARG Human bisphenol A affects methylation ISO Pparg (Mus musculus) 6480464 bisphenol A affects the methylation of PPARG promoter CTD PMID:27334623 PPARG Human bisphenol A increases methylation ISO Pparg (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of PPARG gene CTD PMID:28505145 PPARG Human bisphenol A decreases expression ISO Pparg (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of PPARG mRNA and bisphenol A results in decreased expression of PPARG protein CTD PMID:23399309 more ... PPARG Human bisphenol A affects binding EXP 6480464 bisphenol A analog binds to PPARG protein and bisphenol A binds to PPARG protein CTD PMID:23843199 more ... PPARG Human bisphenol A increases expression EXP 6480464 bisphenol A analog results in increased expression of PPARG mRNA more ... CTD PMID:20064783 more ... PPARG Human bisphenol A increases expression ISO Pparg (Mus musculus) 6480464 bisphenol A results in increased expression of PPARG more ... CTD PMID:18359623 more ... PPARG Human bisphenol A multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] more ... CTD PMID:21622942 more ... PPARG Human bisphenol A multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PPARG protein more ... CTD PMID:23399309 more ... PPARG Human bisphenol A increases expression ISO Pparg (Rattus norvegicus) 6480464 bisphenol A results in increased expression of PPARG mRNA CTD PMID:20019905 more ... PPARG Human bisphenol A multiple interactions ISO Pparg (Mus musculus) 6480464 [1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of PPARG protein more ... CTD PMID:22197818 more ... PPARG Human Bisphenol A diglycidyl ether decreases activity EXP 6480464 2 and 2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein CTD PMID:21543282 PPARG Human Bisphenol A diglycidyl ether decreases activity ISO Pparg (Rattus norvegicus) 6480464 2 and 2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein CTD PMID:27363640 and PMID:34553211 PPARG Human Bisphenol A diglycidyl ether decreases expression ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:22726273 and PMID:37659742 PPARG Human Bisphenol A diglycidyl ether multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:19903033 more ... PPARG Human Bisphenol A diglycidyl ether increases expression ISO Pparg (Mus musculus) 6480464 2 and 2-bis(4-glycidyloxyphenyl)propane results in increased expression of PPARG mRNA CTD PMID:11991651 PPARG Human Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:11030710 more ... PPARG Human Bisphenol A diglycidyl ether multiple interactions ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:11991651 more ... PPARG Human Bisphenol B multiple interactions EXP 6480464 bisphenol B binds to and results in decreased activity of PPARG protein CTD PMID:34186270 PPARG Human bisphenol F multiple interactions EXP 6480464 4 more ... CTD PMID:30138673 more ... PPARG Human bisphenol F diglycidyl ether multiple interactions EXP 6480464 bisphenol F diglycidyl ether inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30138673 PPARG Human bleomycin A2 decreases expression ISO Pparg (Mus musculus) 6480464 Bleomycin results in decreased expression of PPARG mRNA and Bleomycin results in decreased expression of PPARG protein CTD PMID:19147827 and PMID:27153807 PPARG Human bleomycin A2 multiple interactions EXP 6480464 Berberine inhibits the reaction [Bleomycin binds to PPARG protein] CTD PMID:29408570 PPARG Human bleomycin A2 multiple interactions ISO Pparg (Mus musculus) 6480464 lenabasum inhibits the reaction [Bleomycin results in decreased expression of PPARG protein] and Rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA] CTD PMID:19147827 and PMID:27153807 PPARG Human bongkrekic acid increases activity EXP 6480464 Bongkrekic Acid analog results in increased activity of PPARG protein and Bongkrekic Acid results in increased activity of PPARG protein CTD PMID:25786526 PPARG Human boric acid multiple interactions ISO Pparg (Mus musculus) 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA] more ... CTD PMID:28285642 PPARG Human bosentan decreases expression EXP 6480464 Bosentan results in decreased expression of PPARG mRNA CTD PMID:29761207 PPARG Human Bromadiolone multiple interactions ISO Pparg (Mus musculus) 6480464 bromadiolone binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human Bromadiolone multiple interactions EXP 6480464 bromadiolone binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human bromuconazole multiple interactions ISO Pparg (Mus musculus) 6480464 bromuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human bromuconazole decreases expression ISO Pparg (Rattus norvegicus) 6480464 bromuconazole results in decreased expression of PPARG protein CTD PMID:33789219 PPARG Human bromuconazole multiple interactions EXP 6480464 bromuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human bucladesine increases expression ISO Pparg (Mus musculus) 6480464 Bucladesine results in increased expression of PPARG protein CTD PMID:19698295 PPARG Human bucladesine multiple interactions ISO Pparg (Mus musculus) 6480464 [ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA and [ciglitazone co-treated with Bucladesine] results in increased expression of PPARG protein CTD PMID:19698295 PPARG Human buspirone multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Buspirone inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA] CTD PMID:37341015 PPARG Human busulfan affects expression EXP 6480464 Busulfan affects the expression of PPARG mRNA CTD PMID:35641671 PPARG Human Butylbenzyl phthalate multiple interactions ISO Pparg (Mus musculus) 6480464 [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:24155963 more ... PPARG Human Butylbenzyl phthalate increases activity EXP 6480464 butylbenzyl phthalate results in increased activity of PPARG protein CTD PMID:26172262 PPARG Human Butylbenzyl phthalate increases expression ISO Pparg (Mus musculus) 6480464 butylbenzyl phthalate results in increased expression of PPARG mRNA CTD PMID:27923775 and PMID:34520170 PPARG Human Butylbenzyl phthalate affects binding EXP 6480464 butylbenzyl phthalate binds to PPARG protein CTD PMID:23843199 and PMID:32407875 PPARG Human Butylbenzyl phthalate multiple interactions EXP 6480464 butylbenzyl phthalate binds to and results in increased activity of PPARG protein and butylbenzyl phthalate inhibits the reaction [GW 1929 binds to PPARG protein] CTD PMID:24155963 more ... PPARG Human Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 PPARG Human Butylparaben multiple interactions EXP 6480464 butylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 PPARG Human Butylparaben increases response to substance ISO Pparg (Mus musculus) 6480464 PPARG protein results in increased susceptibility to butylparaben CTD PMID:28527915 PPARG Human Butylparaben increases expression ISO Pparg (Mus musculus) 6480464 butylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 more ... PPARG Human Butylparaben multiple interactions ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:22956630 more ... PPARG Human Butylparaben increases activity ISO Pparg (Mus musculus) 6480464 butylparaben results in increased activity of PPARG protein CTD PMID:28527915 PPARG Human butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of PPARG mRNA and Butyric Acid results in increased expression of PPARG protein CTD PMID:10833422 PPARG Human butyric acid multiple interactions EXP 6480464 [Butyric Acid co-treated with Lipopolysaccharides] results in increased expression of PPARG mRNA CTD PMID:29751049 PPARG Human butyric acid multiple interactions ISO Pparg (Mus musculus) 6480464 Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 PPARG Human cadmium atom decreases expression ISO Pparg (Mus musculus) 6480464 Cadmium results in decreased expression of PPARG protein CTD PMID:21848503 PPARG Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPARG protein more ... CTD PMID:32917723 more ... PPARG Human cadmium atom multiple interactions ISO Pparg (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARG mRNA CTD PMID:36200916 PPARG Human cadmium atom increases expression ISO Pparg (Rattus norvegicus) 6480464 Cadmium results in increased expression of PPARG mRNA CTD PMID:25388156 PPARG Human cadmium dichloride decreases expression ISO Pparg (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of PPARG mRNA and Cadmium Chloride results in decreased expression of PPARG protein CTD PMID:23921151 and PMID:31152847 PPARG Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPARG protein more ... CTD PMID:32917723 more ... PPARG Human cadmium dichloride increases expression ISO Pparg (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of PPARG protein CTD PMID:28283887 PPARG Human cadmium dichloride increases expression ISO Pparg (Mus musculus) 6480464 Cadmium Chloride results in increased expression of PPARG mRNA CTD PMID:26352046 PPARG Human cadmium dichloride decreases expression ISO Pparg (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased expression of PPARG mRNA CTD PMID:25993096 PPARG Human cadmium dichloride affects activity EXP 6480464 Cadmium Chloride affects the activity of PPARG protein CTD PMID:25596134 PPARG Human cadmium dichloride multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 and PMID:28283887 PPARG Human cadmium dichloride multiple interactions ISO Pparg (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARG mRNA more ... CTD PMID:23921151 and PMID:36200916 PPARG Human cadmium sulfate multiple interactions ISO Pparg (Mus musculus) 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of PPARG mRNA] CTD PMID:16221973 PPARG Human caffeine decreases expression ISO Pparg (Mus musculus) 6480464 Caffeine results in decreased expression of PPARG mRNA CTD PMID:23727198 PPARG Human caffeine decreases phosphorylation EXP 6480464 Caffeine results in decreased phosphorylation of PPARG protein CTD PMID:35688186 PPARG Human caffeine decreases expression ISO Pparg (Rattus norvegicus) 6480464 Caffeine results in decreased expression of PPARG mRNA CTD PMID:23727198 PPARG Human calciol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Cholecalciferol co-treated with Dietary Fats co-treated with Particulate Matter] results in increased expression of PPARG mRNA CTD PMID:36603807 PPARG Human calcitriol decreases expression ISO Pparg (Mus musculus) 6480464 Calcitriol results in decreased expression of PPARG mRNA and Calcitriol results in decreased expression of PPARG protein CTD PMID:15036392 more ... PPARG Human calcitriol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:29953732 PPARG Human cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of PPARG mRNA CTD PMID:23220503 PPARG Human cannabidiol affects binding EXP 6480464 Cannabidiol analog binds to PPARG protein CTD PMID:30033591 PPARG Human cannabidiol increases activity ISO Pparg (Mus musculus) 6480464 Cannabidiol analog results in increased activity of PPARG protein CTD PMID:30033591 PPARG Human cannabidiol increases expression ISO Pparg (Mus musculus) 6480464 Cannabidiol analog results in increased expression of PPARG mRNA alternative form CTD PMID:30382123 PPARG Human cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of PPARG protein CTD PMID:28853159 PPARG Human cannabidiol multiple interactions ISO Pparg (Mus musculus) 6480464 [lipopolysaccharide more ... CTD PMID:30033591 more ... PPARG Human cannabidiol affects binding ISO Pparg (Mus musculus) 6480464 Cannabidiol binds to PPARG protein CTD PMID:19285060 PPARG Human cannabidiol increases expression ISO Pparg (Rattus norvegicus) 6480464 Cannabidiol results in increased expression of PPARG mRNA CTD PMID:19285060 PPARG Human cannabidiol multiple interactions EXP 6480464 Cannabidiol analog binds to and results in increased activity of PPARG protein more ... CTD PMID:23220503 more ... PPARG Human cannabidiolic acid decreases expression EXP 6480464 cannabidiolic acid results in decreased expression of PPARG protein CTD PMID:28853159 PPARG Human cannabidiolic acid multiple interactions EXP 6480464 cannabidiolic acid binds to and results in increased activity of PPARG protein CTD PMID:30611848 PPARG Human cannabidiolic acid increases expression ISO Pparg (Mus musculus) 6480464 cannabidiolic acid results in increased expression of PPARG mRNA CTD PMID:30611848 PPARG Human cannabidiolic acid multiple interactions ISO Pparg (Mus musculus) 6480464 cannabidiolic acid binds to and results in increased activity of PPARG protein and cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:30611848 PPARG Human cannabidiolic acid increases expression EXP 6480464 cannabidiolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 PPARG Human cannabigerol decreases expression EXP 6480464 cannabigerol results in decreased expression of PPARG protein CTD PMID:28853159 PPARG Human cannabigerol multiple interactions ISO Pparg (Mus musculus) 6480464 cannabigerol binds to and results in increased activity of PPARG protein and cannabigerol promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:30611848 PPARG Human cannabigerol multiple interactions EXP 6480464 cannabigerol binds to and results in increased activity of PPARG protein CTD PMID:30611848 PPARG Human cannabigerol increases expression EXP 6480464 cannabigerol results in increased expression of PPARG mRNA CTD PMID:28853159 PPARG Human cannabigerolic acid increases expression EXP 6480464 cannabigerolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 PPARG Human cannabigerolic acid increases expression ISO Pparg (Mus musculus) 6480464 cannabigerolic acid results in increased expression of PPARG mRNA CTD PMID:30611848 PPARG Human cannabigerolic acid multiple interactions ISO Pparg (Mus musculus) 6480464 cannabigerolic acid binds to and results in increased activity of PPARG protein and cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:30611848 PPARG Human cannabigerolic acid multiple interactions EXP 6480464 cannabigerolic acid binds to and results in increased activity of PPARG protein CTD PMID:30611848 PPARG Human cannabigerolic acid decreases expression EXP 6480464 cannabigerolic acid results in decreased expression of PPARG protein CTD PMID:28853159 PPARG Human capsaicin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:20359164 PPARG Human capsaicin increases activity EXP 6480464 Capsaicin results in increased activity of PPARG protein CTD PMID:15383218 PPARG Human capsaicin decreases expression ISO Pparg (Mus musculus) 6480464 Capsaicin results in decreased expression of PPARG protein CTD PMID:17295509 PPARG Human capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of PPARG mRNA CTD PMID:18769453 PPARG Human capsaicin multiple interactions EXP 6480464 2 and 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Capsaicin results in increased activity of PPARG protein] CTD PMID:15383218 PPARG Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of PPARG mRNA CTD PMID:24752500 PPARG Human carbon monoxide multiple interactions ISO Pparg (Mus musculus) 6480464 [Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein more ... CTD PMID:22046279 PPARG Human carbon nanotube multiple interactions EXP 6480464 PPARG protein affects the reaction [Nanotubes and Carbon results in increased expression of PLIN2 protein] CTD PMID:32649966 PPARG Human carbon nanotube increases expression ISO Pparg (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 and PMID:25926378 PPARG Human carbon nanotube decreases expression ISO Pparg (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 PPARG Human carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:23634900 and PMID:32649966 PPARG Human carnosic acid increases activity EXP 6480464 salvin results in increased activity of PPARG protein CTD PMID:20696231 PPARG Human carotenoid decreases expression ISO Pparg (Mus musculus) 6480464 Carotenoids results in decreased expression of PPARG mRNA CTD PMID:11237167 PPARG Human casticin increases expression EXP 6480464 casticin results in increased expression of PPARG mRNA CTD PMID:27862857 PPARG Human celastrol affects expression ISO Pparg (Mus musculus) 6480464 celastrol affects the expression of PPARG mRNA and celastrol affects the expression of PPARG protein CTD PMID:27085773 PPARG Human celecoxib multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Celecoxib affects the localization of PPARG protein] more ... CTD PMID:19522023 and PMID:23943857 PPARG Human celecoxib multiple interactions ISO Pparg (Mus musculus) 6480464 [Celecoxib co-treated with docetaxel] results in increased expression of PPARG protein CTD PMID:16052515 PPARG Human celecoxib multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:19247274 PPARG Human celecoxib increases expression EXP 6480464 Celecoxib results in increased expression of PPARG mRNA and Celecoxib results in increased expression of PPARG protein CTD PMID:23943857 PPARG Human celecoxib affects localization EXP 6480464 Celecoxib affects the localization of PPARG protein CTD PMID:23943857 PPARG Human cerium decreases expression EXP 6480464 Cerium results in decreased expression of PPARG mRNA CTD PMID:35641671 PPARG Human cerulenin decreases expression ISO Pparg (Mus musculus) 6480464 Cerulenin results in decreased expression of PPARG mRNA CTD PMID:15707987 PPARG Human ceruletide multiple interactions ISO Pparg (Mus musculus) 6480464 PPARG affects the reaction [Ceruletide results in increased expression of CCL2 mRNA] and PPARG affects the reaction [Ceruletide results in increased expression of CXCL1 mRNA] CTD PMID:17463185 PPARG Human chalcone increases expression ISO Pparg (Mus musculus) 6480464 Chalcone analog results in increased expression of PPARG mRNA CTD PMID:28528971 PPARG Human Chebulagic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 chebulagic acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG protein] CTD PMID:34470562 PPARG Human chenodeoxycholic acid increases expression ISO Pparg (Rattus norvegicus) 6480464 Chenodeoxycholic Acid results in increased expression of PPARG mRNA CTD PMID:15980055 PPARG Human chenodeoxycholic acid multiple interactions ISO Pparg (Mus musculus) 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG mRNA] and Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG protein] CTD PMID:35780845 PPARG Human chenodeoxycholic acid increases expression EXP 6480464 Chenodeoxycholic Acid results in increased expression of PPARG mRNA CTD PMID:27174168 PPARG Human CHIR 99021 multiple interactions EXP 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of PPARG mRNA CTD PMID:35267148 PPARG Human chloroacetaldehyde affects activity EXP 6480464 chloroacetaldehyde affects the activity of PPARG protein CTD PMID:25596134 PPARG Human Chlorobenzilate multiple interactions EXP 6480464 chlorobenzilate binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human Chlorobenzilate multiple interactions ISO Pparg (Mus musculus) 6480464 chlorobenzilate binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human chlorogenic acid increases expression ISO Pparg (Mus musculus) 6480464 Chlorogenic Acid results in increased expression of PPARG mRNA CTD PMID:21870829 PPARG Human chlorogenic acid decreases expression EXP 6480464 Chlorogenic Acid results in decreased expression of PPARG mRNA CTD PMID:20706672 PPARG Human chloroquine multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Chloroquine inhibits the reaction [PPARG protein inhibits the reaction [Dexamethasone results in increased expression of NLRP3 protein]] CTD PMID:38286393 PPARG Human chlorothalonil decreases expression ISO Pparg (Mus musculus) 6480464 tetrachloroisophthalonitrile results in decreased expression of PPARG mRNA CTD PMID:33246813 PPARG Human chlorothalonil multiple interactions ISO Pparg (Mus musculus) 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARG mRNA CTD PMID:33246813 PPARG Human chlorpromazine affects activity ISO Pparg (Rattus norvegicus) 6480464 Chlorpromazine affects the activity of PPARG protein CTD PMID:25596134 PPARG Human chlorpyrifos increases expression ISO Pparg (Rattus norvegicus) 6480464 Chlorpyrifos results in increased expression of PPARG mRNA CTD PMID:33994353 PPARG Human chlorpyrifos increases expression ISO Pparg (Mus musculus) 6480464 Chlorpyrifos results in increased expression of PPARG mRNA CTD PMID:37019170 PPARG Human chlorpyrifos multiple interactions ISO Pparg (Mus musculus) 6480464 [Chlorpyrifos co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein and Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:32017950 PPARG Human chlorpyrifos increases methylation EXP 6480464 Chlorpyrifos results in increased methylation of PPARG gene CTD PMID:33540251 PPARG Human chlorpyrifos multiple interactions EXP 6480464 rosiglitazone inhibits the reaction [Chlorpyrifos results in decreased expression of PPARG protein] CTD PMID:24793810 PPARG Human chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of PPARG mRNA and Chlorpyrifos results in decreased expression of PPARG protein CTD PMID:24793810 and PMID:31509763 PPARG Human chlorpyrifos-methyl multiple interactions ISO Pparg (Mus musculus) 6480464 chlorpyrifos-methyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human chlorpyrifos-methyl multiple interactions EXP 6480464 chlorpyrifos-methyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human cholesterol multiple interactions EXP 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of Cholesterol] more ... CTD PMID:12044893 more ... PPARG Human cholesterol multiple interactions ISO Pparg (Mus musculus) 6480464 [Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA more ... CTD PMID:18302760 more ... PPARG Human choline multiple interactions ISO Pparg (Mus musculus) 6480464 3 more ... CTD PMID:18991162 and PMID:28973532 PPARG Human chrysin multiple interactions ISO Pparg (Mus musculus) 6480464 chrysin binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 and PMID:33049310 PPARG Human chrysin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 chrysin inhibits the reaction [Iron-Dextran Complex results in decreased expression of PPARG protein] CTD PMID:38432408 PPARG Human chrysin multiple interactions EXP 6480464 chrysin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human cidofovir anhydrous affects activity EXP 6480464 Cidofovir affects the activity of PPARG protein CTD PMID:25596134 PPARG Human ciglitazone multiple interactions ISO Pparg (Mus musculus) 6480464 [ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA more ... CTD PMID:12847270 more ... PPARG Human ciglitazone affects localization ISO Pparg (Rattus norvegicus) 6480464 ciglitazone affects the localization of PPARG protein CTD PMID:20578043 PPARG Human ciglitazone increases expression ISO Pparg (Mus musculus) 6480464 ciglitazone results in increased expression of PPARG protein CTD PMID:19698295 PPARG Human ciglitazone decreases response to substance EXP 6480464 PPARG protein mutant form results in decreased susceptibility to ciglitazone CTD PMID:19922793 PPARG Human ciglitazone affects binding EXP 6480464 ciglitazone binds to PPARG protein CTD PMID:12839938 and PMID:21511917 PPARG Human ciglitazone increases localization EXP 6480464 ciglitazone results in increased localization of PPARG protein CTD PMID:12517972 PPARG Human ciglitazone increases activity EXP 6480464 ciglitazone results in increased activity of PPARG protein CTD PMID:12517972 more ... PPARG Human ciglitazone increases activity ISO Pparg (Mus musculus) 6480464 ciglitazone results in increased activity of PPARG protein CTD PMID:11683414 and PMID:16023420 PPARG Human ciglitazone multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:16820301 and PMID:18063688 PPARG Human ciglitazone increases expression EXP 6480464 ciglitazone results in increased expression of PPARG mRNA and ciglitazone results in increased expression of PPARG protein CTD PMID:11840453 more ... PPARG Human ciglitazone multiple interactions EXP 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of ABHD3 mRNA more ... CTD PMID:11030710 more ... PPARG Human cilnidipine decreases activity EXP 6480464 cilnidipine results in decreased activity of PPARG protein CTD PMID:25257666 PPARG Human cilostazol increases activity EXP 6480464 cilostazol results in increased activity of PPARG protein CTD PMID:21660147 PPARG Human cilostazol multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [cilostazol results in increased activity of PPARG protein] more ... CTD PMID:21660147 PPARG Human cis-caffeic acid increases expression ISO Pparg (Mus musculus) 6480464 caffeic acid results in increased expression of PPARG mRNA CTD PMID:21870829 PPARG Human cisplatin multiple interactions EXP 6480464 [rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to Cisplatin more ... CTD PMID:21781307 and PMID:27417252 PPARG Human cisplatin affects activity EXP 6480464 Cisplatin affects the activity of PPARG protein CTD PMID:25596134 PPARG Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PPARG protein CTD PMID:27417252 PPARG Human cisplatin affects expression EXP 6480464 Cisplatin affects the expression of PPARG mRNA CTD PMID:23300844 PPARG Human cisplatin decreases expression ISO Pparg (Rattus norvegicus) 6480464 Cisplatin results in decreased expression of PPARG mRNA and Cisplatin results in decreased expression of PPARG protein CTD PMID:22989705 more ... PPARG Human cisplatin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:22989705 more ... PPARG Human Citreoviridin decreases activity ISO Pparg (Rattus norvegicus) 6480464 citreoviridin results in decreased activity of PPARG protein CTD PMID:31419397 PPARG Human Citreoviridin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] and Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:31419397 PPARG Human citronellol multiple interactions EXP 6480464 citronellol inhibits the reaction [PPARG protein results in increased expression of PTGS2 mRNA] CTD PMID:21597168 PPARG Human citronellol increases activity EXP 6480464 citronellol results in increased activity of PPARG protein CTD PMID:21597168 PPARG Human Clinofibrate affects binding EXP 6480464 clinofibrate binds to PPARG protein CTD PMID:11779144 PPARG Human clodronic acid affects activity EXP 6480464 Clodronic Acid affects the activity of PPARG protein CTD PMID:25596134 PPARG Human clofazimine increases expression ISO Pparg (Rattus norvegicus) 6480464 Clofazimine results in increased expression of PPARG mRNA and Clofazimine results in increased expression of PPARG protein CTD PMID:31393584 PPARG Human clofibrate multiple interactions ISO Pparg (Mus musculus) 6480464 [Clofibrate co-treated with PPARG] results in increased expression of FABP4 mRNA more ... CTD PMID:9543393 PPARG Human clofibrate increases expression ISO Pparg (Rattus norvegicus) 6480464 Clofibrate results in increased expression of PPARG mRNA and Clofibrate results in increased expression of PPARG protein CTD PMID:12604186 and PMID:12699904 PPARG Human clofibrate multiple interactions ISO Pparg (Rattus norvegicus) 6480464 PPARG protein promotes the reaction [Clofibrate results in decreased expression of ALDH3A1 mRNA] CTD PMID:12604186 PPARG Human clofibrate affects response to substance ISO Pparg (Rattus norvegicus) 6480464 PPARG protein affects the susceptibility to Clofibrate CTD PMID:12604186 PPARG Human clofibrate multiple interactions EXP 6480464 Clofibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein] CTD PMID:11779144 PPARG Human clofibrate increases response to substance ISO Pparg (Rattus norvegicus) 6480464 PPARG results in increased susceptibility to Clofibrate CTD PMID:12699904 PPARG Human clofibric acid affects binding EXP 6480464 Clofibric Acid binds to PPARG protein CTD PMID:11779144 and PMID:35752307 PPARG Human clofibric acid affects binding ISO Pparg (Rattus norvegicus) 6480464 Clofibric Acid binds to PPARG protein CTD PMID:35752307 PPARG Human Clofop increases activity EXP 6480464 fenofibric acid results in increased activity of PPARG protein CTD PMID:15273253 PPARG Human Clofop multiple interactions EXP 6480464 fenofibric acid results in increased activity of [PPARG protein alternative form binds to RXRA protein] CTD PMID:11779144 PPARG Human Clofop affects binding EXP 6480464 fenofibric acid binds to PPARG protein CTD PMID:11779144 PPARG Human clozapine multiple interactions ISO Pparg (Mus musculus) 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA] and Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein] CTD PMID:20564506 PPARG Human clozapine increases expression ISO Pparg (Mus musculus) 6480464 Clozapine results in increased expression of PPARG mRNA and Clozapine results in increased expression of PPARG protein CTD PMID:20564506 PPARG Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PPARG mRNA CTD PMID:15708366 PPARG Human cobalt dichloride multiple interactions ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:32408695 PPARG Human cobalt dichloride decreases expression ISO Pparg (Mus musculus) 6480464 cobaltous chloride results in decreased expression of PPARG mRNA CTD PMID:20594416 PPARG Human colforsin daropate hydrochloride decreases expression EXP 6480464 Colforsin results in decreased expression of PPARG mRNA CTD PMID:31278978 PPARG Human conjugated linoleic acid decreases activity EXP 6480464 Linoleic Acids and Conjugated results in decreased activity of PPARG protein CTD PMID:18776171 PPARG Human conjugated linoleic acid increases expression ISO Pparg (Mus musculus) 6480464 Linoleic Acids and Conjugated results in increased expression of PPARG mRNA CTD PMID:17322064 PPARG Human conjugated linoleic acid increases expression EXP 6480464 Linoleic Acids more ... CTD PMID:15961301 PPARG Human conjugated linoleic acid multiple interactions EXP 6480464 Linoleic Acids more ... CTD PMID:18776171 PPARG Human conjugated linoleic acid decreases expression EXP 6480464 Linoleic Acids and Conjugated results in decreased expression of PPARG protein CTD PMID:16933788 PPARG Human copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which affects the expression of PPARG mRNA CTD PMID:30911355 PPARG Human copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which affects the expression of PPARG mRNA CTD PMID:30911355 PPARG Human cordycepin decreases expression EXP 6480464 cordycepin results in decreased expression of PPARG mRNA CTD PMID:24286368 PPARG Human cordycepin multiple interactions EXP 6480464 cordycepin inhibits the reaction [[Dexamethasone co-treated with Insulin co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:34575692 PPARG Human cordycepin multiple interactions ISO Pparg (Mus musculus) 6480464 4-nitrobenzylthioinosine inhibits the reaction [cordycepin results in decreased expression of PPARG mRNA] and cordycepin results in decreased expression of and results in decreased activity of PPARG protein CTD PMID:22537056 PPARG Human cordycepin decreases expression ISO Pparg (Mus musculus) 6480464 cordycepin results in decreased expression of PPARG mRNA CTD PMID:20107539 and PMID:22537056 PPARG Human corilagin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 corilagin inhibits the reaction [Doxorubicin results in increased expression of PPARG protein] CTD PMID:34605098 PPARG Human corticosterone multiple interactions ISO Pparg (Mus musculus) 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA and Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 PPARG Human cortisol multiple interactions EXP 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA more ... CTD PMID:33476690 PPARG Human cortisone multiple interactions ISO Pparg (Mus musculus) 6480464 2-(3-benzoyl)-4-hydroxy-1 more ... CTD PMID:21315688 PPARG Human cortisone increases expression ISO Pparg (Mus musculus) 6480464 Cortisone results in increased expression of PPARG mRNA CTD PMID:21315688 PPARG Human coumaphos multiple interactions EXP 6480464 Coumaphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human coumaphos multiple interactions ISO Pparg (Mus musculus) 6480464 Coumaphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human crocidolite asbestos increases expression EXP 6480464 Asbestos more ... CTD PMID:23634900 PPARG Human cucurbitacin B multiple interactions ISO Pparg (Mus musculus) 6480464 STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of PPARG mRNA] CTD PMID:24316209 PPARG Human cucurbitacin B decreases expression ISO Pparg (Mus musculus) 6480464 cucurbitacin B results in decreased expression of PPARG mRNA CTD PMID:24316209 PPARG Human cucurbitacin I decreases expression ISO Pparg (Mus musculus) 6480464 cucurbitacin I results in decreased expression of PPARG mRNA CTD PMID:24316209 PPARG Human curcumin affects binding EXP 6480464 Curcumin binds to PPARG protein CTD PMID:15713005 PPARG Human curcumin decreases expression ISO Pparg (Mus musculus) 6480464 Curcumin results in decreased expression of PPARG mRNA CTD PMID:23603106 PPARG Human curcumin increases expression ISO Pparg (Rattus norvegicus) 6480464 Curcumin results in increased expression of PPARG mRNA and Curcumin results in increased expression of PPARG protein CTD PMID:16959952 more ... PPARG Human curcumin increases activity ISO Pparg (Rattus norvegicus) 6480464 Curcumin results in increased activity of PPARG protein CTD PMID:18332871 PPARG Human curcumin decreases expression ISO Pparg (Rattus norvegicus) 6480464 Curcumin results in decreased expression of PPARG protein CTD PMID:19225048 PPARG Human curcumin affects localization ISO Pparg (Rattus norvegicus) 6480464 Curcumin affects the localization of PPARG protein CTD PMID:17531121 PPARG Human curcumin multiple interactions ISO Pparg (Mus musculus) 6480464 Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] more ... CTD PMID:19297423 more ... PPARG Human curcumin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:16782535 more ... PPARG Human curcumin multiple interactions EXP 6480464 PPARG protein promotes the reaction [Curcumin results in decreased expression of CCN2 mRNA] CTD PMID:17965732 PPARG Human curcumin increases activity EXP 6480464 Curcumin results in increased activity of PPARG protein CTD PMID:15486348 PPARG Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of PPARG protein modified form CTD PMID:15486348 PPARG Human cyanamide multiple interactions EXP 6480464 Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] CTD PMID:17030193 PPARG Human cyanocob(III)alamin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] and Vitamin B 12 inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:23935743 PPARG Human cyclophosphamide increases expression ISO Pparg (Rattus norvegicus) 6480464 Cyclophosphamide results in increased expression of PPARG mRNA CTD PMID:27281708 PPARG Human cyclophosphamide decreases expression ISO Pparg (Rattus norvegicus) 6480464 Cyclophosphamide results in decreased expression of PPARG mRNA CTD PMID:25446862 PPARG Human cyclophosphamide multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of PPARG mRNA] CTD PMID:25446862 PPARG Human cyclosporin A multiple interactions EXP 6480464 [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein CTD PMID:17016853 PPARG Human cyclosporin A affects activity ISO Pparg (Rattus norvegicus) 6480464 Cyclosporine affects the activity of PPARG protein CTD PMID:25596134 PPARG Human cyclosporin A affects activity EXP 6480464 Cyclosporine affects the activity of PPARG protein CTD PMID:25596134 PPARG Human cyclosporin A decreases expression ISO Pparg (Rattus norvegicus) 6480464 Cyclosporine results in decreased expression of PPARG mRNA and Cyclosporine results in decreased expression of PPARG protein CTD PMID:17461532 PPARG Human cyclosporin A multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Cyclosporine inhibits the reaction [rosiglitazone results in increased expression of PPARG protein] more ... CTD PMID:17461532 PPARG Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of PPARG mRNA CTD PMID:20106945 PPARG Human cyfluthrin multiple interactions ISO Pparg (Mus musculus) 6480464 cyfluthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human cyfluthrin multiple interactions EXP 6480464 cyfluthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human cyhalothrin increases expression ISO Pparg (Rattus norvegicus) 6480464 cyhalothrin results in increased expression of PPARG mRNA CTD PMID:27348886 PPARG Human cyhalothrin multiple interactions EXP 6480464 [cyhalothrin co-treated with Oleic Acid] results in increased expression of PPARG protein and Metformin inhibits the reaction [[cyhalothrin co-treated with Oleic Acid] results in increased expression of PPARG protein] CTD PMID:36529352 PPARG Human cyhalothrin decreases expression ISO Pparg (Mus musculus) 6480464 cyhalothrin results in decreased expression of PPARG mRNA CTD PMID:36529352 PPARG Human cyhalothrin affects expression ISO Pparg (Mus musculus) 6480464 cyhalothrin affects the expression of PPARG protein CTD PMID:36529352 PPARG Human cypermethrin multiple interactions ISO Pparg (Mus musculus) 6480464 cypermethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human cypermethrin multiple interactions EXP 6480464 cypermethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human cyproterone acetate multiple interactions EXP 6480464 Cyproterone Acetate binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human cyproterone acetate multiple interactions ISO Pparg (Mus musculus) 6480464 Cyproterone Acetate binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human cytarabine multiple interactions ISO Pparg (Mus musculus) 6480464 2 and 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA] CTD PMID:23264188 PPARG Human cytarabine increases expression ISO Pparg (Mus musculus) 6480464 Cytarabine results in increased expression of PPARG mRNA CTD PMID:23264188 PPARG Human D-glucose multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... PPARG Human D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 PPARG Human D-glucose multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 more ... PPARG Human D-glucose decreases expression ISO Pparg (Rattus norvegicus) 6480464 Glucose results in decreased expression of PPARG mRNA and Glucose results in decreased expression of PPARG protein CTD PMID:19609456 and PMID:31063766 PPARG Human daunorubicin decreases activity EXP 6480464 Daunorubicin results in decreased activity of PPARG protein CTD PMID:25257666 PPARG Human daunorubicin increases expression ISO Pparg (Rattus norvegicus) 6480464 Daunorubicin results in increased expression of PPARG protein CTD PMID:20888384 PPARG Human daunorubicin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] CTD PMID:20888384 PPARG Human DDD multiple interactions ISO Pparg (Mus musculus) 6480464 Dichlorodiphenyldichloroethane binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human DDE multiple interactions EXP 6480464 [Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA CTD PMID:26200599 PPARG Human DDT increases expression EXP 6480464 DDT results in increased expression of PPARG mRNA CTD PMID:25014179 PPARG Human DDT multiple interactions EXP 6480464 DDT binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human DDT multiple interactions ISO Pparg (Mus musculus) 6480464 DDT binds to and results in increased activity of PPARG protein and DDT results in increased activity of and results in increased localization of PPARG protein CTD PMID:11911853 and PMID:33049310 PPARG Human decabromodiphenyl ether increases expression ISO Pparg (Mus musculus) 6480464 decabromobiphenyl ether results in increased expression of PPARG protein CTD PMID:30743236 PPARG Human decanoic acid affects binding EXP 6480464 decanoic acid binds to PPARG protein CTD PMID:24998974 PPARG Human decanoic acid increases activity EXP 6480464 decanoic acid results in increased activity of PPARG protein CTD PMID:24998974 PPARG Human Delta(9)-tetrahydrocannabinolic acid increases expression EXP 6480464 delta(9)-tetrahydrocannabinolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 PPARG Human Delta(9)-tetrahydrocannabinolic acid multiple interactions EXP 6480464 delta(9)-tetrahydrocannabinolic acid inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:28853159 PPARG Human Delta(9)-tetrahydrocannabinolic acid decreases expression EXP 6480464 delta(9)-tetrahydrocannabinolic acid results in decreased expression of PPARG protein CTD PMID:28853159 PPARG Human delta-tocopherol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA] and [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 PPARG Human demethoxycurcumin affects binding EXP 6480464 demethoxycurcumin binds to PPARG protein CTD PMID:15713005 PPARG Human deoxycholic acid decreases expression ISO Pparg (Mus musculus) 6480464 Deoxycholic Acid results in decreased expression of PPARG mRNA CTD PMID:23911798 PPARG Human deoxynivalenol multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:18485432 PPARG Human deoxynivalenol multiple interactions ISO Pparg (Mus musculus) 6480464 [Selenomethionine co-treated with deoxynivalenol] results in increased expression of PPARG mRNA CTD PMID:38040082 PPARG Human deoxynivalenol decreases activity EXP 6480464 deoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 PPARG Human deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of PPARG mRNA CTD PMID:18485432 PPARG Human dexamethasone multiple interactions ISO Pparg (Mus musculus) 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein] more ... CTD PMID:11101056 more ... PPARG Human dexamethasone decreases expression ISO Pparg (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of PPARG protein CTD PMID:38286393 PPARG Human dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of PPARG mRNA and Dexamethasone results in increased expression of PPARG protein CTD PMID:16569937 more ... PPARG Human dexamethasone increases expression ISO Pparg (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of PPARG mRNA and Dexamethasone results in increased expression of PPARG protein CTD PMID:14568882 and PMID:19118567 PPARG Human dexamethasone increases expression ISO Pparg (Mus musculus) 6480464 Dexamethasone results in increased expression of PPARG mRNA more ... CTD PMID:16814746 more ... PPARG Human dexamethasone multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA more ... CTD PMID:16782535 more ... PPARG Human dexamethasone decreases expression ISO Pparg (Mus musculus) 6480464 Dexamethasone results in decreased expression of PPARG mRNA CTD PMID:16889531 PPARG Human dexamethasone multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:17290005 more ... PPARG Human dextran sulfate increases expression ISO Pparg (Mus musculus) 6480464 Dextran Sulfate results in increased expression of PPARG protein CTD PMID:23261717 PPARG Human dextran sulfate multiple interactions ISO Pparg (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA more ... CTD PMID:29950665 and PMID:33130971 PPARG Human dextran sulfate affects localization ISO Pparg (Mus musculus) 6480464 Dextran Sulfate affects the localization of PPARG protein CTD PMID:33130971 PPARG Human Di-n-decyl phthalate affects binding EXP 6480464 didecyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human Di-n-hexyl phthalate affects binding EXP 6480464 di-n-hexyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human diallyl trisulfide decreases expression ISO Pparg (Mus musculus) 6480464 diallyl trisulfide results in decreased expression of PPARG mRNA and diallyl trisulfide results in decreased expression of PPARG protein CTD PMID:22137902 PPARG Human diallyl trisulfide multiple interactions ISO Pparg (Mus musculus) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide results in decreased expression of and results in decreased activity of PPARG protein] more ... CTD PMID:22137902 PPARG Human diallyl trisulfide decreases activity ISO Pparg (Mus musculus) 6480464 diallyl trisulfide results in decreased activity of PPARG protein CTD PMID:22137902 PPARG Human diarsenic trioxide decreases response to substance EXP 6480464 PPARG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 PPARG Human diarsenic trioxide decreases expression ISO Pparg (Rattus norvegicus) 6480464 Arsenic Trioxide results in decreased expression of PPARG mRNA CTD PMID:31258454 PPARG Human diarsenic trioxide multiple interactions ISO Pparg (Mus musculus) 6480464 Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein] more ... CTD PMID:15916724 and PMID:30362509 PPARG Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of PPARG mRNA and Arsenic Trioxide results in increased expression of PPARG protein CTD PMID:22684020 and PMID:34108876 PPARG Human diarsenic trioxide multiple interactions EXP 6480464 [Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide more ... CTD PMID:22684020 more ... PPARG Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:30362509 PPARG Human diarsenic trioxide decreases expression ISO Pparg (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:15916724 and PMID:30362509 PPARG Human diazinon increases activity EXP 6480464 Diazinon results in increased activity of PPARG protein CTD PMID:28728110 PPARG Human diazinon multiple interactions ISO Pparg (Mus musculus) 6480464 Fulvestrant inhibits the reaction [Diazinon results in increased expression of PPARG protein] CTD PMID:33872936 PPARG Human diazinon increases expression ISO Pparg (Mus musculus) 6480464 Diazinon results in increased expression of PPARG protein CTD PMID:33872936 PPARG Human dibutyl phthalate multiple interactions EXP 6480464 Dibutyl Phthalate binds to and results in increased activity of PPARG protein CTD PMID:24155963 more ... PPARG Human dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PPARG protein CTD PMID:29061543 PPARG Human dibutyl phthalate increases activity EXP 6480464 Dibutyl Phthalate results in increased activity of PPARG protein CTD PMID:26172262 PPARG Human dibutyl phthalate multiple interactions ISO Pparg (Mus musculus) 6480464 Dibutyl Phthalate binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human dibutyl phthalate affects binding EXP 6480464 Dibutyl Phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human dibutylstannane multiple interactions EXP 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of PPARG mRNA] CTD PMID:29787037 PPARG Human dibutylstannane increases expression EXP 6480464 di-n-butyltin results in increased expression of PPARG mRNA CTD PMID:29787037 PPARG Human dibutylstannane increases expression ISO Pparg (Mus musculus) 6480464 di-n-butyltin results in increased expression of PPARG mRNA CTD PMID:29787037 PPARG Human dichloroacetic acid increases expression ISO Pparg (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of PPARG mRNA CTD PMID:28962523 PPARG Human diclofenac affects expression EXP 6480464 Diclofenac affects the expression of PPARG mRNA CTD PMID:24752500 PPARG Human diclofenac multiple interactions EXP 6480464 Diclofenac inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30138673 PPARG Human diclofenac increases activity EXP 6480464 Diclofenac results in increased activity of PPARG protein CTD PMID:12065695 more ... PPARG Human diethyl phthalate affects binding EXP 6480464 diethyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human diethyl phthalate decreases expression ISO Pparg (Mus musculus) 6480464 diethyl phthalate results in decreased expression of PPARG protein CTD PMID:37942807 PPARG Human diethylstilbestrol multiple interactions ISO Pparg (Mus musculus) 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of PPARG protein] more ... CTD PMID:22710028 and PMID:26944108 PPARG Human diethylstilbestrol increases activity ISO Pparg (Mus musculus) 6480464 Diethylstilbestrol results in increased activity of PPARG protein CTD PMID:22710028 PPARG Human diethylstilbestrol increases expression ISO Pparg (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of PPARG mRNA and Diethylstilbestrol results in increased expression of PPARG protein CTD PMID:22710028 PPARG Human difenoconazole increases expression ISO Pparg (Mus musculus) 6480464 difenoconazole results in increased expression of PPARG protein CTD PMID:34425431 PPARG Human diheptyl phthalate affects binding EXP 6480464 diheptyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human diisobutyl phthalate multiple interactions EXP 6480464 diisobutyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:24155963 and PMID:27633901 PPARG Human diisobutyl phthalate increases expression EXP 6480464 diisobutyl phthalate results in increased expression of PPARG protein CTD PMID:29061543 PPARG Human diisobutyl phthalate increases activity EXP 6480464 diisobutyl phthalate results in increased activity of PPARG protein CTD PMID:26172262 PPARG Human Diisodecyl phthalate affects binding EXP 6480464 diisodecyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human Diisodecyl phthalate multiple interactions EXP 6480464 diisodecyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:29410257 PPARG Human Diisodecyl phthalate increases expression ISO Pparg (Mus musculus) 6480464 diisodecyl phthalate results in increased expression of PPARG mRNA CTD PMID:29410257 PPARG Human diisononyl phthalate affects binding EXP 6480464 diisononyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human diisononyl phthalate affects expression ISO Pparg (Mus musculus) 6480464 diisononyl phthalate affects the expression of PPARG mRNA CTD PMID:31577137 PPARG Human diisononyl phthalate increases expression ISO Pparg (Mus musculus) 6480464 diisononyl phthalate results in increased expression of PPARG mRNA CTD PMID:29410257 PPARG Human diisononyl phthalate multiple interactions EXP 6480464 diisononyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:29410257 PPARG Human diisononyl phthalate affects activity EXP 6480464 diisononyl phthalate affects the activity of PPARG protein CTD PMID:26172262 PPARG Human dimethomorph multiple interactions EXP 6480464 dimethomorph binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human dimethomorph multiple interactions ISO Pparg (Mus musculus) 6480464 dimethomorph binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human Dimethyl phthalate affects binding EXP 6480464 dimethyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human dimethyl sulfoxide decreases expression EXP 6480464 Dimethyl Sulfoxide results in decreased expression of PPARG mRNA CTD PMID:21878375 PPARG Human dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of PPARG mRNA CTD PMID:23221991 PPARG Human dimethylarsinic acid multiple interactions EXP 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA CTD PMID:28793237 PPARG Human dimethylarsinic acid decreases expression ISO Pparg (Mus musculus) 6480464 Cacodylic Acid results in decreased expression of PPARG mRNA CTD PMID:23221991 PPARG Human diniconazole multiple interactions ISO Pparg (Mus musculus) 6480464 diniconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human diniconazole multiple interactions EXP 6480464 diniconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human diosgenin increases expression ISO Pparg (Mus musculus) 6480464 Diosgenin results in increased expression of PPARG protein CTD PMID:24001619 PPARG Human diosgenin increases expression EXP 6480464 Diosgenin results in increased expression of PPARG mRNA CTD PMID:32347045 PPARG Human diosgenin decreases response to substance ISO Pparg (Mus musculus) 6480464 PPARG protein results in decreased susceptibility to Diosgenin CTD PMID:26408789 PPARG Human diosgenin decreases expression ISO Pparg (Mus musculus) 6480464 Diosgenin results in decreased expression of PPARG mRNA CTD PMID:26408789 PPARG Human diosgenin multiple interactions ISO Pparg (Mus musculus) 6480464 [Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]] which results in decreased activity of PPARG protein more ... CTD PMID:26408789 PPARG Human dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of PPARG protein CTD PMID:19520921 PPARG Human dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARG mRNA more ... CTD PMID:34995009 PPARG Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of PPARG mRNA CTD PMID:26516004 PPARG Human dioxygen affects activity EXP 6480464 Oxygen deficiency affects the activity of PPARG protein CTD PMID:25596134 PPARG Human dioxygen affects expression ISO Pparg (Mus musculus) 6480464 Oxygen deficiency affects the expression of PPARG protein CTD PMID:28859903 PPARG Human dioxygen increases expression ISO Pparg (Mus musculus) 6480464 Oxygen deficiency results in increased expression of PPARG protein and Oxygen results in increased expression of PPARG mRNA CTD PMID:21113404 and PMID:22535284 PPARG Human dioxygen decreases expression ISO Pparg (Rattus norvegicus) 6480464 Oxygen results in decreased expression of PPARG mRNA and Oxygen results in decreased expression of PPARG protein CTD PMID:16617452 PPARG Human dioxygen multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:16617452 more ... PPARG Human dioxygen multiple interactions ISO Pparg (Mus musculus) 6480464 [Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form more ... CTD PMID:16814746 more ... PPARG Human dioxygen decreases expression ISO Pparg (Mus musculus) 6480464 Oxygen deficiency results in decreased expression of PPARG mRNA and Oxygen deficiency results in decreased expression of PPARG protein CTD PMID:21531777 PPARG Human dipentyl phthalate affects binding EXP 6480464 di-n-pentyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human dipentyl phthalate multiple interactions EXP 6480464 di-n-pentyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human dipentyl phthalate multiple interactions ISO Pparg (Mus musculus) 6480464 di-n-pentyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human Diphenolic acid multiple interactions EXP 6480464 diphenolic acid binds to and results in decreased activity of PPARG protein CTD PMID:33049310 PPARG Human dipropyl phthalate affects binding EXP 6480464 di-n-propylphthalate binds to PPARG protein CTD PMID:23843199 PPARG Human disodium selenite multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA] and Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:21705299 and PMID:31419397 PPARG Human disodium selenite increases activity ISO Pparg (Rattus norvegicus) 6480464 Sodium Selenite results in increased activity of PPARG protein CTD PMID:31419397 PPARG Human disodium selenite increases expression ISO Pparg (Rattus norvegicus) 6480464 Sodium Selenite results in increased expression of PPARG protein CTD PMID:24140496 PPARG Human disulfiram multiple interactions EXP 6480464 Disulfiram binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human disulfiram affects expression EXP 6480464 Disulfiram affects the expression of PPARG mRNA CTD PMID:32712770 PPARG Human disulfiram multiple interactions ISO Pparg (Mus musculus) 6480464 Disulfiram binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human Dithiopyr multiple interactions EXP 6480464 dithiopyr binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human Dithiopyr multiple interactions ISO Pparg (Mus musculus) 6480464 dithiopyr binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human diuron increases expression ISO Pparg (Rattus norvegicus) 6480464 Diuron results in increased expression of PPARG mRNA CTD PMID:21551480 PPARG Human diuron multiple interactions ISO Pparg (Mus musculus) 6480464 Diuron binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human dodecylamine multiple interactions ISO Pparg (Mus musculus) 6480464 dodecylamine binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human dodecylamine multiple interactions EXP 6480464 dodecylamine binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human doramapimod increases expression ISO Pparg (Mus musculus) 6480464 doramapimod results in increased expression of PPARG mRNA CTD PMID:21328587 PPARG Human dorsomorphin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 dorsomorphin inhibits the reaction [25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein] CTD PMID:33676887 PPARG Human dorsomorphin multiple interactions ISO Pparg (Mus musculus) 6480464 dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]] CTD PMID:30446312 PPARG Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:24584901 more ... PPARG Human doxorubicin decreases activity EXP 6480464 Doxorubicin results in decreased activity of PPARG protein CTD PMID:25257666 PPARG Human doxorubicin increases expression ISO Pparg (Rattus norvegicus) 6480464 Doxorubicin results in increased expression of PPARG protein CTD PMID:34605098 PPARG Human doxorubicin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein] more ... CTD PMID:30836069 and PMID:34605098 PPARG Human doxorubicin decreases expression ISO Pparg (Rattus norvegicus) 6480464 Doxorubicin results in decreased expression of PPARG protein CTD PMID:30836069 PPARG Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of PPARG mRNA and Doxorubicin results in decreased expression of PPARG protein CTD PMID:27417252 and PMID:29803840 PPARG Human doxorubicin multiple interactions EXP 6480464 [15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Doxorubicin and [nimesulide co-treated with Doxorubicin] results in increased expression of PPARG CTD PMID:14567645 and PMID:23964924 PPARG Human efavirenz decreases expression EXP 6480464 efavirenz results in decreased expression of PPARG mRNA CTD PMID:21619898 PPARG Human elemental selenium multiple interactions ISO Pparg (Mus musculus) 6480464 PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide more ... CTD PMID:17439952 PPARG Human ellagic acid increases expression EXP 6480464 Ellagic Acid results in increased expression of PPARG protein CTD PMID:23811531 PPARG Human emodin increases expression EXP 6480464 Emodin results in increased expression of PPARG protein CTD PMID:25448808 PPARG Human emodin multiple interactions EXP 6480464 Emodin results in increased stability of and results in increased expression of PPARG mRNA CTD PMID:25448808 PPARG Human enalapril decreases expression ISO Pparg (Rattus norvegicus) 6480464 Enalapril results in decreased expression of PPARG protein CTD PMID:19225048 PPARG Human enalapril multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Enalapril inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein] CTD PMID:30623541 PPARG Human endosulfan increases expression ISO Pparg (Rattus norvegicus) 6480464 Endosulfan results in increased expression of PPARG mRNA CTD PMID:29391264 PPARG Human endrin decreases expression ISO Pparg (Mus musculus) 6480464 Endrin results in decreased expression of PPARG protein CTD PMID:10385688 PPARG Human endrin increases expression ISO Pparg (Mus musculus) 6480464 Endrin results in increased expression of PPARG mRNA CTD PMID:34801515 PPARG Human endrin multiple interactions ISO Pparg (Mus musculus) 6480464 MK 2206 inhibits the reaction [Endrin results in increased expression of PPARG mRNA] and Sirolimus inhibits the reaction [Endrin results in increased expression of PPARG mRNA] CTD PMID:34801515 PPARG Human enilconazole multiple interactions EXP 6480464 enilconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human enilconazole multiple interactions ISO Pparg (Mus musculus) 6480464 enilconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human epoxiconazole affects expression ISO Pparg (Mus musculus) 6480464 epoxiconazole affects the expression of PPARG mRNA CTD PMID:35436446 PPARG Human epoxomicin multiple interactions ISO Pparg (Mus musculus) 6480464 epoxomicin inhibits the reaction [resveratrol results in decreased expression of PPARG protein] and epoxomicin inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein] CTD PMID:18555852 PPARG Human equilin multiple interactions ISO Pparg (Mus musculus) 6480464 Equilin binds to and results in decreased activity of PPARG protein CTD PMID:33049310 PPARG Human esculetin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 esculetin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] and esculetin inhibits the reaction [Streptozocin results in increased expression of PPARG protein] CTD PMID:21450970 PPARG Human esculetin multiple interactions ISO Pparg (Mus musculus) 6480464 esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA] CTD PMID:27769711 PPARG Human Ethalfluralin multiple interactions EXP 6480464 ethafluralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human Ethalfluralin multiple interactions ISO Pparg (Mus musculus) 6480464 ethafluralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human ethanol multiple interactions EXP 6480464 Cyanamide inhibits the reaction [Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]] more ... CTD PMID:17030193 more ... PPARG Human ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PPARG mRNA and Ethanol results in decreased expression of PPARG protein CTD PMID:28062356 and PMID:34192554 PPARG Human ethanol decreases expression ISO Pparg (Rattus norvegicus) 6480464 [Ethanol results in decreased expression of PPARG protein] which results in decreased expression of ADIPOQ protein more ... CTD PMID:24412557 PPARG Human ethanol increases expression ISO Pparg (Rattus norvegicus) 6480464 Ethanol results in increased expression of PPARG mRNA and Ethanol results in increased expression of PPARG protein CTD PMID:18793633 more ... PPARG Human ethanol increases expression ISO Pparg (Mus musculus) 6480464 Ethanol results in increased expression of PPARG mRNA and Ethanol results in increased expression of PPARG protein CTD PMID:18620774 more ... PPARG Human ethanol increases expression EXP 6480464 Ethanol results in increased expression of PPARG mRNA CTD PMID:24144995 PPARG Human ethanol affects expression ISO Pparg (Mus musculus) 6480464 Ethanol affects the expression of PPARG mRNA CTD PMID:19167417 PPARG Human ethanol multiple interactions ISO Pparg (Mus musculus) 6480464 [ADORA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased expression of PPARG mRNA more ... CTD PMID:18755807 more ... PPARG Human ethanol decreases expression ISO Pparg (Mus musculus) 6480464 Ethanol results in decreased expression of PPARG mRNA and Ethanol results in decreased expression of PPARG protein CTD PMID:22173916 and PMID:34192554 PPARG Human ethanol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA more ... CTD PMID:15318101 more ... PPARG Human ethyl 3,4-dihydroxybenzoate multiple interactions ISO Pparg (Mus musculus) 6480464 ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:24338020 PPARG Human ethyl myristate multiple interactions EXP 6480464 ethyl myristate binds to and results in decreased activity of PPARG protein CTD PMID:27633901 PPARG Human ethylparaben increases expression ISO Pparg (Mus musculus) 6480464 ethyl-p-hydroxybenzoate results in increased expression of PPARG mRNA CTD PMID:22956630 PPARG Human eugenol multiple interactions EXP 6480464 Eugenol analog binds to and results in increased activity of PPARG protein CTD PMID:20064974 PPARG Human eugenol increases expression ISO Pparg (Mus musculus) 6480464 Eugenol results in increased expression of PPARG mRNA CTD PMID:21870829 PPARG Human eugenol multiple interactions ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:20064974 PPARG Human Evodiamine decreases expression ISO Pparg (Mus musculus) 6480464 evodiamine results in decreased expression of PPARG CTD PMID:17884939 PPARG Human farglitazar increases expression ISO Pparg (Rattus norvegicus) 6480464 farglitazar results in increased expression of PPARG mRNA CTD PMID:15475592 PPARG Human farglitazar multiple interactions ISO Pparg (Mus musculus) 6480464 farglitazar binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human farglitazar multiple interactions EXP 6480464 farglitazar binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human farnesol increases expression EXP 6480464 Farnesol analog results in increased expression of PPARG mRNA CTD PMID:30611723 PPARG Human farnesol multiple interactions EXP 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARG mRNA CTD PMID:30611723 PPARG Human fenamiphos multiple interactions EXP 6480464 fenamiphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fenamiphos multiple interactions ISO Pparg (Mus musculus) 6480464 fenamiphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fenarimol multiple interactions ISO Pparg (Mus musculus) 6480464 fenarimol binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fenarimol multiple interactions EXP 6480464 fenarimol binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fenchone multiple interactions EXP 6480464 fenchone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 PPARG Human fenitrothion multiple interactions ISO Pparg (Mus musculus) 6480464 Fenitrothion binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fenitrothion multiple interactions EXP 6480464 Fenitrothion binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of PPARG mRNA CTD PMID:19201410 and PMID:28034800 PPARG Human fenofibrate affects activity ISO Pparg (Rattus norvegicus) 6480464 Fenofibrate affects the activity of PPARG protein CTD PMID:25596134 PPARG Human fenofibrate affects activity EXP 6480464 Fenofibrate affects the activity of PPARG protein CTD PMID:25596134 PPARG Human fenofibrate multiple interactions EXP 6480464 [Oleic Acid co-treated with Fenofibrate] results in increased expression of PPARG mRNA CTD PMID:24534255 PPARG Human fenofibrate increases expression ISO Pparg (Mus musculus) 6480464 Fenofibrate results in increased expression of PPARG mRNA CTD PMID:19201410 PPARG Human fenoprofen multiple interactions EXP 6480464 Fenoprofen binds to and results in increased activity of PPARG protein CTD PMID:9013583 PPARG Human fenthion increases expression EXP 6480464 Fenthion results in increased expression of PPARG mRNA CTD PMID:32473317 PPARG Human fenthion multiple interactions EXP 6480464 Fenthion binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fenthion multiple interactions ISO Pparg (Mus musculus) 6480464 Fenthion binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fentin chloride multiple interactions EXP 6480464 diphenyltin chloride inhibits the reaction [triphenyltin chloride binds to PPARG protein] more ... CTD PMID:19497422 and PMID:33049310 PPARG Human fentin chloride multiple interactions ISO Pparg (Rattus norvegicus) 6480464 triphenyltin chloride results in increased expression of and affects the localization of PPARG protein CTD PMID:37156404 PPARG Human fentin chloride increases expression ISO Pparg (Mus musculus) 6480464 triphenyltin chloride results in increased expression of PPARG protein CTD PMID:37142754 PPARG Human fentin chloride increases activity EXP 6480464 triphenyltin chloride results in increased activity of PPARG protein CTD PMID:26172262 PPARG Human fentin chloride multiple interactions ISO Pparg (Mus musculus) 6480464 [triphenyltin chloride co-treated with tributyltin co-treated with dibutyldichlorotin] results in increased expression of PPARG protein more ... CTD PMID:33049310 and PMID:37142754 PPARG Human fentin hydroxide increases expression EXP 6480464 triphenyltin hydroxide results in increased expression of PPARG mRNA CTD PMID:32473317 PPARG Human ferulic acid increases expression ISO Pparg (Mus musculus) 6480464 ferulic acid results in increased expression of PPARG mRNA CTD PMID:21870829 PPARG Human ferulic acid multiple interactions ISO Pparg (Mus musculus) 6480464 ferulic acid inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein] CTD PMID:37393015 PPARG Human finasteride multiple interactions ISO Pparg (Mus musculus) 6480464 Finasteride binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fipronil increases expression ISO Pparg (Mus musculus) 6480464 fipronil results in increased expression of PPARG mRNA and fipronil results in increased expression of PPARG protein CTD PMID:27103584 PPARG Human fipronil increases expression EXP 6480464 fipronil results in increased expression of PPARG mRNA CTD PMID:38050659 PPARG Human flavanone increases expression EXP 6480464 flavanone results in increased expression of PPARG protein CTD PMID:22056764 PPARG Human flavonoids decreases expression ISO Pparg (Rattus norvegicus) 6480464 Flavonoids results in decreased expression of PPARG mRNA CTD PMID:23238999 PPARG Human fluconazole increases expression ISO Pparg (Rattus norvegicus) 6480464 Fluconazole results in increased expression of PPARG mRNA CTD PMID:20623750 PPARG Human fludioxonil multiple interactions ISO Pparg (Mus musculus) 6480464 fludioxonil binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fludioxonil multiple interactions EXP 6480464 fludioxonil binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human flufenamic acid multiple interactions EXP 6480464 [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein and Flufenamic Acid binds to and results in increased activity of PPARG protein CTD PMID:10866999 and PMID:9013583 PPARG Human flufenamic acid increases activity EXP 6480464 Flufenamic Acid results in increased activity of PPARG protein CTD PMID:10866999 PPARG Human Flumetralin multiple interactions ISO Pparg (Mus musculus) 6480464 flumetralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fluoranthene multiple interactions EXP 6480464 fluoranthene binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fluoxastrobin multiple interactions EXP 6480464 fluoxastrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 PPARG Human fluoxetine multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein] CTD PMID:25766885 PPARG Human fluoxetine multiple interactions ISO Pparg (Rattus norvegicus) 6480464 vinpocetine inhibits the reaction [Fluoxetine results in decreased expression of PPARG mRNA] and vinpocetine inhibits the reaction [Fluoxetine results in decreased expression of PPARG protein] CTD PMID:34669537 PPARG Human fluoxetine decreases expression ISO Pparg (Rattus norvegicus) 6480464 Fluoxetine results in decreased expression of PPARG mRNA and Fluoxetine results in decreased expression of PPARG protein CTD PMID:34669537 PPARG Human fluoxetine increases expression ISO Pparg (Rattus norvegicus) 6480464 Fluoxetine results in increased expression of PPARG mRNA CTD PMID:34897744 PPARG Human fluprostenol multiple interactions ISO Pparg (Mus musculus) 6480464 fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA] CTD PMID:21236357 PPARG Human flutamide multiple interactions EXP 6480464 Flutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human flutamide multiple interactions ISO Pparg (Mus musculus) 6480464 Flutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human fluticasone multiple interactions EXP 6480464 Fluticasone promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]] CTD PMID:15531761 PPARG Human flutolanil increases activity EXP 6480464 flutolanil results in increased activity of PPARG protein CTD PMID:20143881 PPARG Human folic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] and Folic Acid inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:23935743 PPARG Human folic acid multiple interactions ISO Pparg (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA CTD PMID:22206623 PPARG Human fomepizole multiple interactions EXP 6480464 fomepizole inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] CTD PMID:17030193 PPARG Human fructose increases expression ISO Pparg (Rattus norvegicus) 6480464 Fructose results in increased expression of PPARG mRNA CTD PMID:19196556 PPARG Human fructose multiple interactions ISO Pparg (Mus musculus) 6480464 [Dietary Fats co-treated with Cholesterol more ... CTD PMID:37271273 PPARG Human fructose decreases activity ISO Pparg (Rattus norvegicus) 6480464 Fructose results in decreased activity of PPARG protein CTD PMID:25679220 PPARG Human fructose multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein more ... CTD PMID:19196556 more ... PPARG Human fucoxanthin decreases expression ISO Pparg (Mus musculus) 6480464 fucoxanthin results in decreased expression of PPARG mRNA CTD PMID:20519145 PPARG Human fulvestrant multiple interactions ISO Pparg (Mus musculus) 6480464 Fulvestrant inhibits the reaction [Antimony results in increased expression of PPARG protein] more ... CTD PMID:22710028 more ... PPARG Human fulvestrant multiple interactions EXP 6480464 Fulvestrant inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] and PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]] CTD PMID:32623698 PPARG Human fumonisin B2 decreases activity EXP 6480464 fumonisin B2 results in decreased activity of PPARG protein CTD PMID:27481073 PPARG Human furan decreases expression ISO Pparg (Rattus norvegicus) 6480464 furan results in decreased expression of PPARG mRNA CTD PMID:25539665 and PMID:26194646 PPARG Human Fusarenone X decreases activity EXP 6480464 fusarenon-X results in decreased activity of PPARG protein CTD PMID:27481073 PPARG Human gadobutrol decreases expression ISO Pparg (Mus musculus) 6480464 gadobutrol results in decreased expression of PPARG mRNA CTD PMID:37437671 PPARG Human gadodiamide hydrate decreases expression ISO Pparg (Mus musculus) 6480464 gadodiamide results in decreased expression of PPARG mRNA and gadodiamide results in decreased expression of PPARG protein CTD PMID:37437671 PPARG Human gadolinium trichloride decreases expression ISO Pparg (Mus musculus) 6480464 gadolinium chloride results in decreased expression of PPARG mRNA CTD PMID:37437671 PPARG Human gallic acid increases expression ISO Pparg (Mus musculus) 6480464 Gallic Acid results in increased expression of PPARG protein CTD PMID:24036142 PPARG Human gallic acid increases activity ISO Pparg (Rattus norvegicus) 6480464 Gallic Acid results in increased activity of PPARG protein CTD PMID:24433871 PPARG Human gallocatechin decreases expression ISO Pparg (Rattus norvegicus) 6480464 gallocatechol results in decreased expression of PPARG mRNA CTD PMID:21877759 PPARG Human gamma-linolenic acid multiple interactions EXP 6480464 gamma-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:15318936 PPARG Human gamma-tocopherol increases expression EXP 6480464 gamma-Tocopherol results in increased expression of PPARG mRNA and gamma-Tocopherol results in increased expression of PPARG protein CTD PMID:14521714 PPARG Human gamma-tocopherol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA] and [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 PPARG Human Ganoderic acid A multiple interactions ISO Pparg (Mus musculus) 6480464 [Dietary Fats co-treated with ganoderic acid A] affects the expression of PPARG mRNA CTD PMID:29852127 PPARG Human gemcitabine affects expression ISO Pparg (Mus musculus) 6480464 Gemcitabine affects the expression of PPARG mRNA CTD PMID:19427843 PPARG Human gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of PPARG mRNA CTD PMID:19201410 PPARG Human gemfibrozil increases expression ISO Pparg (Mus musculus) 6480464 Gemfibrozil results in increased expression of PPARG mRNA CTD PMID:19201410 PPARG Human genistein decreases expression ISO Pparg (Mus musculus) 6480464 Genistein results in decreased expression of PPARG mRNA CTD PMID:18359623 PPARG Human genistein increases expression ISO Pparg (Rattus norvegicus) 6480464 Genistein results in increased expression of PPARG mRNA CTD PMID:24361872 PPARG Human genistein decreases expression EXP 6480464 Genistein results in decreased expression of PPARG mRNA CTD PMID:20706672 PPARG Human genistein multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:19903033 and PMID:27171397 PPARG Human genistein increases activity ISO Pparg (Rattus norvegicus) 6480464 Genistein results in increased activity of PPARG protein CTD PMID:19903033 PPARG Human Geraniin decreases expression ISO Pparg (Mus musculus) 6480464 Geraniin results in decreased expression of PPARG protein CTD PMID:36706894 PPARG Human Geraniin multiple interactions ISO Pparg (Mus musculus) 6480464 STO 609 inhibits the reaction [Geraniin results in decreased expression of PPARG protein] CTD PMID:36706894 PPARG Human geraniol decreases expression EXP 6480464 geraniol results in decreased expression of PPARG mRNA CTD PMID:27683099 PPARG Human geraniol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 geraniol inhibits the reaction [Fructose results in decreased activity of PPARG protein] more ... CTD PMID:25679220 and PMID:26165751 PPARG Human geraniol increases activity EXP 6480464 geraniol results in increased activity of PPARG protein CTD PMID:21597168 PPARG Human geraniol multiple interactions ISO Pparg (Mus musculus) 6480464 geraniol inhibits the reaction [[lipopolysaccharide more ... CTD PMID:30550845 PPARG Human Gingerenone A multiple interactions ISO Pparg (Mus musculus) 6480464 gingerenone A inhibits the reaction [INS protein results in increased expression of PPARG protein] CTD PMID:28556482 PPARG Human gingerol multiple interactions ISO Pparg (Mus musculus) 6480464 gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA] more ... CTD PMID:22285432 and PMID:26498061 PPARG Human gingerol decreases expression ISO Pparg (Mus musculus) 6480464 gingerol results in decreased expression of PPARG mRNA and gingerol results in decreased expression of PPARG protein CTD PMID:26498061 PPARG Human ginsenoside Re increases expression ISO Pparg (Mus musculus) 6480464 ginsenoside Re results in increased expression of PPARG mRNA CTD PMID:23545455 PPARG Human Ginsenoside Rh4 multiple interactions ISO Pparg (Mus musculus) 6480464 ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PPARG mRNA] CTD PMID:33359794 PPARG Human gliclazide multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein] CTD PMID:32045587 PPARG Human glucose multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... PPARG Human glucose decreases expression EXP 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 PPARG Human glucose multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 more ... PPARG Human glucose decreases expression ISO Pparg (Rattus norvegicus) 6480464 Glucose results in decreased expression of PPARG mRNA and Glucose results in decreased expression of PPARG protein CTD PMID:19609456 and PMID:31063766 PPARG Human Glutathione ethyl ester multiple interactions ISO Pparg (Mus musculus) 6480464 S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA] CTD PMID:21520053 PPARG Human glyburide multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA] and Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:29223569 PPARG Human glycerol multiple interactions ISO Pparg (Rattus norvegicus) 6480464 ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein] CTD PMID:16820301 PPARG Human glycerol decreases expression ISO Pparg (Rattus norvegicus) 6480464 Glycerol results in decreased expression of PPARG protein CTD PMID:16820301 PPARG Human glycerol 2-phosphate multiple interactions ISO Pparg (Mus musculus) 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:14505802 and PMID:32473317 PPARG Human glycerol 2-phosphate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA CTD PMID:25932594 PPARG Human glycine increases expression ISO Pparg (Mus musculus) 6480464 Glycine results in increased expression of PPARG mRNA CTD PMID:18930730 PPARG Human glycycoumarin affects binding EXP 6480464 glycycoumarin binds to PPARG protein CTD PMID:14608046 PPARG Human glycyrrhetinate multiple interactions ISO Pparg (Rattus norvegicus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA] and 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:28414158 PPARG Human glycyrrhetinic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA] and 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:28414158 PPARG Human glycyrrhizinic acid multiple interactions ISO Pparg (Mus musculus) 6480464 Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:34302803 PPARG Human gossypetin affects response to substance ISO Pparg (Mus musculus) 6480464 PPARG protein affects the susceptibility to gossypetin CTD PMID:23845592 PPARG Human griseofulvin increases expression ISO Pparg (Mus musculus) 6480464 Griseofulvin results in increased expression of PPARG mRNA CTD PMID:9548566 PPARG Human GW 1929 multiple interactions EXP 6480464 [GW 1929 binds to and results in increased activity of PPARG protein] promotes the reaction [TNF protein results in decreased susceptibility to FSHB protein] more ... CTD PMID:20008677 more ... PPARG Human GW 1929 increases expression ISO Pparg (Rattus norvegicus) 6480464 GW 1929 results in increased expression of PPARG mRNA CTD PMID:19420904 PPARG Human GW 1929 multiple interactions ISO Pparg (Mus musculus) 6480464 4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 1929 results in increased expression of PPARG mRNA] more ... CTD PMID:12847270 more ... PPARG Human GW 1929 increases expression ISO Pparg (Mus musculus) 6480464 GW 1929 results in increased expression of PPARG mRNA CTD PMID:20516370 PPARG Human GW 1929 affects binding EXP 6480464 GW 1929 binds to PPARG protein CTD PMID:20008677 more ... PPARG Human GW 1929 increases activity EXP 6480464 GW 1929 results in increased activity of PPARG protein CTD PMID:21543282 PPARG Human GW 4064 increases expression ISO Pparg (Rattus norvegicus) 6480464 GW 4064 results in increased expression of PPARG mRNA CTD PMID:15980055 PPARG Human GW 4064 multiple interactions EXP 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of PPARG mRNA CTD PMID:30611723 PPARG Human GW 4064 increases expression EXP 6480464 GW 4064 results in increased expression of PPARG mRNA CTD PMID:30611723 PPARG Human GW 501516 increases expression EXP 6480464 GW 501516 results in increased expression of PPARG mRNA CTD PMID:19201410 PPARG Human GW 501516 increases expression ISO Pparg (Mus musculus) 6480464 GW 501516 results in increased expression of PPARG mRNA CTD PMID:19201410 PPARG Human GW 501516 increases activity EXP 6480464 GW 501516 results in increased activity of PPARG protein CTD PMID:16386710 PPARG Human GW 7647 multiple interactions EXP 6480464 GW 7647 binds to and results in increased activity of PPARG protein and PPARG protein promotes the reaction [GW 7647 results in increased activity of DIO2 protein] CTD PMID:19036883 PPARG Human GW 7647 multiple interactions ISO Pparg (Mus musculus) 6480464 [PPARA protein co-treated with GW 7647] results in increased expression of PPARG mRNA CTD PMID:21324916 PPARG Human GW 7647 increases activity EXP 6480464 GW 7647 results in increased activity of PPARG protein CTD PMID:20143881 PPARG Human gypenoside LXXV multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [gypenoside LXXV binds to and results in increased activity of PPARG protein] and gypenoside LXXV binds to and results in increased activity of PPARG protein CTD PMID:35192202 PPARG Human gypenoside LXXV multiple interactions ISO Pparg (Mus musculus) 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [gypenoside LXXV results in increased expression of PPARG protein] CTD PMID:35192202 PPARG Human gypenoside LXXV increases expression ISO Pparg (Mus musculus) 6480464 gypenoside LXXV results in increased expression of PPARG protein CTD PMID:35192202 and PMID:36325883 PPARG Human harmine multiple interactions ISO Pparg (Mus musculus) 6480464 [phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA CTD PMID:20519739 PPARG Human harmine increases expression ISO Pparg (Mus musculus) 6480464 Harmine results in increased expression of PPARG protein CTD PMID:27805061 PPARG Human hesperetin decreases expression EXP 6480464 hesperetin results in decreased expression of PPARG mRNA and hesperetin results in decreased expression of PPARG protein CTD PMID:25345581 PPARG Human hesperetin multiple interactions ISO Pparg (Mus musculus) 6480464 [hesperetin analog co-treated with PPARG protein] affects the reaction [Lipopolysaccharides results in increased expression of TNF protein] more ... CTD PMID:28428136 PPARG Human hesperidin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]] more ... CTD PMID:24954035 more ... PPARG Human hesperidin multiple interactions ISO Pparg (Mus musculus) 6480464 Hesperidin affects the reaction [LEPR protein affects the expression of PPARG protein] CTD PMID:16427799 PPARG Human HET0016 multiple interactions ISO Pparg (Rattus norvegicus) 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]] CTD PMID:31063766 PPARG Human hexadecanoic acid increases expression ISO Pparg (Mus musculus) 6480464 Palmitic Acid results in increased expression of PPARG mRNA and Palmitic Acid results in increased expression of PPARG protein CTD PMID:18154422 more ... PPARG Human hexadecanoic acid multiple interactions ISO Pparg (Mus musculus) 6480464 [Palmitic Acid co-treated with Ethanol] results in increased expression of PPARG mRNA more ... CTD PMID:30208301 more ... PPARG Human hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of PPARG protein CTD PMID:30208301 PPARG Human hexadecanoic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA more ... CTD PMID:30208301 more ... PPARG Human hexadecanoic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:25048947 more ... PPARG Human hexadecanoic acid decreases expression ISO Pparg (Rattus norvegicus) 6480464 Palmitic Acid results in decreased expression of PPARG mRNA CTD PMID:25108154 PPARG Human hispidulin multiple interactions ISO Pparg (Mus musculus) 6480464 hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA] and hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein] CTD PMID:30055130 PPARG Human Honokiol multiple interactions EXP 6480464 ALOX15 protein promotes the reaction [honokiol results in decreased expression of PPARG protein] and honokiol binds to and results in increased activity of PPARG protein CTD PMID:20649594 and PMID:23811337 PPARG Human Honokiol decreases expression ISO Pparg (Mus musculus) 6480464 honokiol results in decreased expression of PPARG protein CTD PMID:20649594 PPARG Human Honokiol decreases expression EXP 6480464 honokiol results in decreased expression of PPARG mRNA and honokiol results in decreased expression of PPARG protein CTD PMID:20649594 PPARG Human hydrazine decreases expression ISO Pparg (Rattus norvegicus) 6480464 hydrazine results in decreased expression of PPARG mRNA CTD PMID:15370871 PPARG Human hydrazines decreases expression ISO Pparg (Mus musculus) 6480464 Hydrazines results in decreased expression of PPARG mRNA and Hydrazines results in decreased expression of PPARG protein CTD PMID:21647536 PPARG Human hydrogen peroxide multiple interactions EXP 6480464 bergenin inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] more ... CTD PMID:17030193 more ... PPARG Human hydrogen peroxide increases degradation EXP 6480464 Hydrogen Peroxide results in increased degradation of PPARG protein CTD PMID:25305479 PPARG Human hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of PPARG protein CTD PMID:27417252 and PMID:34499403 PPARG Human hydrogen peroxide affects abundance ISO Pparg (Mus musculus) 6480464 PPARG protein affects the abundance of Hydrogen Peroxide CTD PMID:18083318 PPARG Human hydrogen peroxide decreases abundance ISO Pparg (Mus musculus) 6480464 PPARG gene polymorphism results in decreased abundance of Hydrogen Peroxide CTD PMID:18083318 PPARG Human hydrogen peroxide multiple interactions ISO Pparg (Rattus norvegicus) 6480464 stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] CTD PMID:17302992 PPARG Human hydrogen peroxide decreases expression ISO Pparg (Rattus norvegicus) 6480464 Hydrogen Peroxide results in decreased expression of PPARG protein CTD PMID:17302992 PPARG Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of PPARG mRNA CTD PMID:20044591 PPARG Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of PPARG mRNA CTD PMID:25130202 PPARG Human hydroquinone multiple interactions ISO Pparg (Mus musculus) 6480464 [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of PPARG mRNA CTD PMID:37245849 PPARG Human hydroxyflutamide multiple interactions ISO Pparg (Mus musculus) 6480464 hydroxyflutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human hydroxyflutamide multiple interactions EXP 6480464 hydroxyflutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human hydroxysafflor yellow A multiple interactions ISO Pparg (Rattus norvegicus) 6480464 hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]] more ... CTD PMID:24192212 PPARG Human hydroxytyrosol decreases expression ISO Pparg (Mus musculus) 6480464 3 and 4-dihydroxyphenylethanol results in decreased expression of PPARG mRNA CTD PMID:21569430 PPARG Human ibuprofen multiple interactions ISO Pparg (Mus musculus) 6480464 Ibuprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA] and Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein] CTD PMID:16407166 and PMID:18946735 PPARG Human ibuprofen affects activity ISO Pparg (Rattus norvegicus) 6480464 Ibuprofen affects the activity of PPARG protein CTD PMID:25596134 PPARG Human ibuprofen affects activity EXP 6480464 Ibuprofen affects the activity of PPARG protein CTD PMID:25596134 PPARG Human ibuprofen increases expression ISO Pparg (Mus musculus) 6480464 Ibuprofen results in increased expression of PPARG mRNA CTD PMID:16407166 PPARG Human ibuprofen increases activity ISO Pparg (Rattus norvegicus) 6480464 Ibuprofen analog results in increased activity of PPARG protein CTD PMID:11755111 PPARG Human ibuprofen multiple interactions EXP 6480464 Ibuprofen binds to and results in increased activity of PPARG protein CTD PMID:9013583 PPARG Human Icaritin increases expression EXP 6480464 icaritin results in increased expression of PPARG mRNA and icaritin results in increased expression of PPARG protein CTD PMID:34153405 PPARG Human Icaritin multiple interactions ISO Pparg (Mus musculus) 6480464 icaritin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA] more ... CTD PMID:34153405 PPARG Human Icaritin multiple interactions EXP 6480464 icaritin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA] CTD PMID:34153405 PPARG Human Icaritin increases expression ISO Pparg (Mus musculus) 6480464 icaritin results in increased expression of PPARG mRNA and icaritin results in increased expression of PPARG protein CTD PMID:34153405 PPARG Human idarubicin decreases activity EXP 6480464 Idarubicin results in decreased activity of PPARG protein CTD PMID:25257666 PPARG Human ifosfamide affects activity EXP 6480464 Ifosfamide affects the activity of PPARG protein CTD PMID:25596134 PPARG Human indinavir decreases expression ISO Pparg (Mus musculus) 6480464 Indinavir results in decreased expression of PPARG mRNA CTD PMID:17926646 PPARG Human indole-3-methanol affects expression ISO Pparg (Rattus norvegicus) 6480464 indole-3-carbinol affects the expression of PPARG mRNA CTD PMID:21396975 PPARG Human indometacin multiple interactions EXP 6480464 2 more ... CTD PMID:12485869 more ... PPARG Human indometacin decreases expression ISO Pparg (Rattus norvegicus) 6480464 Indomethacin results in decreased expression of PPARG mRNA CTD PMID:36868495 PPARG Human indometacin multiple interactions ISO Pparg (Mus musculus) 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA more ... CTD PMID:30055130 and PMID:33412187 PPARG Human indometacin increases activity EXP 6480464 Indomethacin analog results in increased activity of PPARG protein and Indomethacin results in increased activity of PPARG protein CTD PMID:12065695 more ... PPARG Human indometacin increases activity ISO Pparg (Rattus norvegicus) 6480464 Indomethacin results in increased activity of PPARG protein CTD PMID:11755111 PPARG Human indometacin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Indomethacin inhibits the reaction [rosiglitazone binds to and affects the activity of PPARG protein] CTD PMID:12897060 PPARG Human indometacin increases activity ISO Pparg (Mus musculus) 6480464 Indomethacin results in increased activity of PPARG protein CTD PMID:11683414 PPARG Human indometacin increases expression EXP 6480464 Indomethacin results in increased expression of PPARG mRNA and Indomethacin results in increased expression of PPARG protein CTD PMID:12483719 more ... PPARG Human indometacin affects localization EXP 6480464 Indomethacin affects the localization of PPARG protein CTD PMID:15899809 PPARG Human Ingenol 3,20-dibenzoate increases activity EXP 6480464 ingenol dibenzoate results in increased activity of PPARG protein CTD PMID:15707588 PPARG Human insulin multiple interactions EXP 6480464 [Dexamethasone co-treated with Insulin co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA and cordycepin inhibits the reaction [[Dexamethasone co-treated with Insulin co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:34575692 PPARG Human iohexol increases expression EXP 6480464 Iohexol results in increased expression of PPARG mRNA CTD PMID:29705293 PPARG Human iprodione increases activity EXP 6480464 iprodione results in increased activity of PPARG protein CTD PMID:20143881 PPARG Human iprodione multiple interactions ISO Pparg (Mus musculus) 6480464 iprodione binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human iprodione multiple interactions EXP 6480464 iprodione binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human irinotecan multiple interactions EXP 6480464 Luteolin inhibits the reaction [Irinotecan results in decreased expression of PPARG mRNA] more ... CTD PMID:34699766 PPARG Human irinotecan decreases expression EXP 6480464 Irinotecan results in decreased expression of PPARG mRNA CTD PMID:34699766 PPARG Human iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of PPARG mRNA CTD PMID:20368581 PPARG Human iron dextran multiple interactions ISO Pparg (Rattus norvegicus) 6480464 bergenin inhibits the reaction [Iron-Dextran Complex results in decreased expression of PPARG protein] and chrysin inhibits the reaction [Iron-Dextran Complex results in decreased expression of PPARG protein] CTD PMID:36207002 and PMID:38432408 PPARG Human iron dextran decreases expression ISO Pparg (Rattus norvegicus) 6480464 Iron-Dextran Complex results in decreased expression of PPARG protein CTD PMID:36207002 and PMID:38432408 PPARG Human iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of PPARG mRNA CTD PMID:20368581 PPARG Human isoliquiritigenin multiple interactions ISO Pparg (Mus musculus) 6480464 isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of PPARG protein] CTD PMID:27117918 PPARG Human isoniazide decreases expression EXP 6480464 Isoniazid results in decreased expression of PPARG mRNA CTD PMID:24128855 PPARG Human isoniazide multiple interactions ISO Pparg (Mus musculus) 6480464 [Isoniazid co-treated with Rifampin] results in decreased expression of PPARG protein CTD PMID:36347327 PPARG Human isoniazide decreases expression ISO Pparg (Mus musculus) 6480464 Isoniazid results in decreased expression of PPARG mRNA and Isoniazid results in decreased expression of PPARG protein CTD PMID:24128855 PPARG Human isonicotinamide decreases expression ISO Pparg (Mus musculus) 6480464 isonicotinamide results in decreased expression of PPARG mRNA CTD PMID:16813520 PPARG Human isophorone multiple interactions EXP 6480464 isophorone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 PPARG Human isoprenaline multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein] more ... CTD PMID:24954035 and PMID:30623541 PPARG Human isoprenaline decreases expression ISO Pparg (Rattus norvegicus) 6480464 Isoproterenol results in decreased expression of PPARG mRNA and Isoproterenol results in decreased expression of PPARG protein CTD PMID:24286936 and PMID:30623541 PPARG Human isoprenaline multiple interactions ISO Pparg (Mus musculus) 6480464 osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] CTD PMID:21854795 PPARG Human isoprenaline decreases expression ISO Pparg (Mus musculus) 6480464 Isoproterenol results in decreased expression of PPARG mRNA CTD PMID:21854795 PPARG Human isorhamnetin multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [3-methylquercetin results in increased activity of PPARG protein] and 3-methylquercetin binds to and results in increased activity of PPARG protein CTD PMID:22992727 PPARG Human isorhamnetin increases expression EXP 6480464 3-methylquercetin results in increased expression of PPARG protein CTD PMID:22992727 PPARG Human isotretinoin increases expression ISO Pparg (Rattus norvegicus) 6480464 Isotretinoin results in increased expression of PPARG mRNA CTD PMID:19041696 and PMID:19212007 PPARG Human ivermectin multiple interactions ISO Pparg (Mus musculus) 6480464 Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] and Rosiglitazone affects the reaction [Ivermectin affects the expression of PPARG mRNA] CTD PMID:31199990 PPARG Human ivermectin affects expression ISO Pparg (Mus musculus) 6480464 Ivermectin affects the expression of PPARG mRNA CTD PMID:31199990 PPARG Human juglone multiple interactions EXP 6480464 [Indomethacin co-treated with juglone] results in increased expression of PPARG mRNA and [Indomethacin co-treated with juglone] results in increased expression of PPARG protein CTD PMID:31916655 PPARG Human juglone increases expression EXP 6480464 juglone results in increased expression of PPARG mRNA and juglone results in increased expression of PPARG protein CTD PMID:31916655 PPARG Human kaempferol multiple interactions ISO Pparg (Mus musculus) 6480464 kaempferol binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 more ... PPARG Human kaempferol increases expression EXP 6480464 kaempferol results in increased expression of PPARG mRNA and kaempferol results in increased expression of PPARG protein CTD PMID:25765892 PPARG Human kaempferol multiple interactions EXP 6480464 [kaempferol co-treated with Luteolin] inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA] more ... CTD PMID:33049310 and PMID:37308028 PPARG Human kresoxim-methyl multiple interactions EXP 6480464 kresoxim-methyl inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 PPARG Human L-ascorbic acid multiple interactions ISO Pparg (Mus musculus) 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:14505802 and PMID:32473317 PPARG Human L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA CTD PMID:25932594 PPARG Human L-methionine multiple interactions ISO Pparg (Mus musculus) 6480464 3 more ... CTD PMID:18991162 and PMID:28973532 PPARG Human L-methionine decreases expression ISO Pparg (Mus musculus) 6480464 Methionine results in decreased expression of PPARG mRNA CTD PMID:35314295 PPARG Human L-methionine decreases methylation ISO Pparg (Mus musculus) 6480464 Methionine deficiency results in decreased methylation of PPARG promoter CTD PMID:35314295 PPARG Human lacidipine increases activity EXP 6480464 lacidipine results in increased activity of PPARG protein CTD PMID:25257666 PPARG Human lactucin multiple interactions ISO Pparg (Mus musculus) 6480464 lactucin affects the reaction [Dietary Fats affects the expression of PPARG mRNA] and lactucin affects the reaction [Dietary Fats affects the expression of PPARG protein] CTD PMID:32023857 PPARG Human lamotrigine decreases expression ISO Pparg (Rattus norvegicus) 6480464 Lamotrigine results in decreased expression of PPARG protein CTD PMID:38050455 PPARG Human lamotrigine multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Curcumin inhibits the reaction [Lamotrigine results in decreased expression of PPARG protein] CTD PMID:38050455 PPARG Human lead diacetate multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 and PMID:28283887 PPARG Human lead diacetate increases expression ISO Pparg (Rattus norvegicus) 6480464 lead acetate results in increased expression of PPARG protein CTD PMID:28283887 PPARG Human lead(0) increases expression ISO Pparg (Rattus norvegicus) 6480464 Lead results in increased expression of PPARG mRNA CTD PMID:23086611 PPARG Human lead(0) increases expression ISO Pparg (Mus musculus) 6480464 Lead results in increased expression of PPARG and Lead results in increased expression of PPARG mRNA CTD PMID:23086611 more ... PPARG Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of PPARG mRNA CTD PMID:28988120 PPARG Human letrozole decreases expression ISO Pparg (Rattus norvegicus) 6480464 Letrozole results in decreased expression of PPARG mRNA CTD PMID:33491863 PPARG Human letrozole multiple interactions ISO Pparg (Rattus norvegicus) 6480464 ADM protein inhibits the reaction [Letrozole results in decreased expression of PPARG mRNA] CTD PMID:33491863 PPARG Human Licarin A multiple interactions ISO Pparg (Mus musculus) 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA and [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein CTD PMID:29288687 PPARG Human linoleamide increases activity EXP 6480464 linoleamide analog results in increased activity of PPARG protein CTD PMID:29288688 PPARG Human linoleic acid affects binding EXP 6480464 Linoleic Acid binds to PPARG protein CTD PMID:23843199 and PMID:35752307 PPARG Human linoleic acid affects binding ISO Pparg (Mus musculus) 6480464 Linoleic Acid binds to PPARG protein CTD PMID:12021203 PPARG Human linoleic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Linoleic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 PPARG Human linoleic acid increases expression ISO Pparg (Mus musculus) 6480464 Linoleic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 PPARG Human linoleic acid multiple interactions ISO Pparg (Mus musculus) 6480464 Linoleic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 PPARG Human linoleic acid multiple interactions EXP 6480464 resveratrol inhibits the reaction [Linoleic Acid results in increased expression of PPARG protein] CTD PMID:25672876 PPARG Human linoleic acid increases expression EXP 6480464 Linoleic Acid results in increased expression of PPARG protein CTD PMID:25672876 PPARG Human linoleic acid increases activity EXP 6480464 Linoleic Acid results in increased activity of PPARG protein CTD PMID:25786526 PPARG Human linoleic acid decreases expression EXP 6480464 Linoleic Acid results in decreased expression of PPARG mRNA and Linoleic Acid results in decreased expression of PPARG protein CTD PMID:11172467 and PMID:15708366 PPARG Human linuron multiple interactions EXP 6480464 Linuron binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human linuron multiple interactions ISO Pparg (Mus musculus) 6480464 Linuron binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human lipoic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA CTD PMID:22464149 PPARG Human lipopolysaccharide multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:15318101 more ... PPARG Human lipopolysaccharide decreases activity ISO Pparg (Rattus norvegicus) 6480464 Lipopolysaccharides results in decreased activity of PPARG protein CTD PMID:29480285 PPARG Human lipopolysaccharide decreases expression ISO Pparg (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of PPARG mRNA and Lipopolysaccharides results in decreased expression of PPARG protein CTD PMID:16847310 more ... PPARG Human lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of PPARG mRNA CTD PMID:12604364 PPARG Human lipopolysaccharide multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:12604364 more ... PPARG Human lipopolysaccharide multiple interactions ISO Pparg (Mus musculus) 6480464 15-deoxy-delta(12 more ... CTD PMID:11343698 more ... PPARG Human lipopolysaccharide increases activity ISO Pparg (Mus musculus) 6480464 Lipopolysaccharides results in increased activity of PPARG protein CTD PMID:27329536 PPARG Human lipoxin A4 multiple interactions ISO Pparg (Rattus norvegicus) 6480464 lipoxin A4 binds to and results in increased activity of PPARG protein CTD PMID:19321784 PPARG Human lithium chloride increases expression EXP 6480464 Lithium Chloride results in increased expression of PPARG mRNA CTD PMID:23527032 PPARG Human loliolide decreases expression ISO Pparg (Mus musculus) 6480464 loliolide results in decreased expression of PPARG protein CTD PMID:33567534 PPARG Human losartan multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of PPARG mRNA] CTD PMID:19109942 PPARG Human losartan multiple interactions ISO Pparg (Mus musculus) 6480464 Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA] CTD PMID:18302760 PPARG Human lovastatin multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein] more ... CTD PMID:16425225 and PMID:26863638 PPARG Human lovastatin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] more ... CTD PMID:20578043 PPARG Human lovastatin affects localization EXP 6480464 Lovastatin analog affects the localization of PPARG protein CTD PMID:26863638 PPARG Human lovastatin increases expression ISO Pparg (Rattus norvegicus) 6480464 Lovastatin results in increased expression of PPARG mRNA CTD PMID:20578043 PPARG Human lovastatin multiple interactions ISO Pparg (Mus musculus) 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of PPARG mRNA and PPARG affects the reaction [Lovastatin results in increased expression of PTEN protein] CTD PMID:16425225 and PMID:29852127 PPARG Human luteolin multiple interactions EXP 6480464 [kaempferol co-treated with Luteolin] inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA] more ... CTD PMID:34699766 and PMID:37308028 PPARG Human luteolin increases expression EXP 6480464 Luteolin results in increased expression of PPARG mRNA CTD PMID:34699766 PPARG Human luzindole multiple interactions EXP 6480464 luzindole inhibits the reaction [Melatonin results in increased expression of PPARG protein] and luzindole inhibits the reaction [Pioglitazone results in increased expression of PPARG protein] CTD PMID:29734669 PPARG Human LY294002 increases expression ISO Pparg (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG protein CTD PMID:17372590 PPARG Human lycopene increases expression ISO Pparg (Mus musculus) 6480464 Lycopene results in increased expression of PPARG mRNA CTD PMID:36216167 PPARG Human lycopene multiple interactions ISO Pparg (Mus musculus) 6480464 [Lycopene co-treated with Atrazine] results in increased expression of PPARG mRNA CTD PMID:36216167 PPARG Human m-xylene decreases expression ISO Pparg (Rattus norvegicus) 6480464 3-xylene results in decreased expression of PPARG mRNA CTD PMID:12815608 PPARG Human Magnolol multiple interactions ISO Pparg (Mus musculus) 6480464 2 more ... CTD PMID:20064974 PPARG Human Magnolol multiple interactions EXP 6480464 magnolol binds to and results in increased activity of PPARG protein CTD PMID:20064974 PPARG Human manganese atom multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [1 and 1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 PPARG Human manganese(0) multiple interactions ISO Pparg (Rattus norvegicus) 6480464 [1 and 1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 PPARG Human mangiferin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 2 more ... CTD PMID:29223569 more ... PPARG Human mangiferin multiple interactions ISO Pparg (Mus musculus) 6480464 [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein CTD PMID:32417366 PPARG Human manidipine decreases activity EXP 6480464 manidipine results in decreased activity of PPARG protein CTD PMID:25257666 PPARG Human melatonin decreases expression EXP 6480464 Melatonin results in decreased expression of PPARG mRNA CTD PMID:20738756 PPARG Human melatonin increases expression EXP 6480464 Melatonin results in increased expression of PPARG mRNA and Melatonin results in increased expression of PPARG protein CTD PMID:29734669 and PMID:33962019 PPARG Human melatonin multiple interactions EXP 6480464 GW 1929 inhibits the reaction [Melatonin results in increased expression of PPARG protein] more ... CTD PMID:29734669 PPARG Human mercury dichloride decreases expression ISO Pparg (Mus musculus) 6480464 Mercuric Chloride results in decreased expression of PPARG mRNA and Mercuric Chloride results in decreased expression of PPARG protein CTD PMID:12883084 and PMID:22019852 PPARG Human mercury dichloride increases expression ISO Pparg (Rattus norvegicus) 6480464 Mercuric Chloride results in increased expression of PPARG mRNA CTD PMID:30807803 PPARG Human mesalamine multiple interactions ISO Pparg (Mus musculus) 6480464 Mesalamine inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein] CTD PMID:33130971 PPARG Human mesalamine multiple interactions EXP 6480464 [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased expression of PPARG protein and Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of PPARG protein] CTD PMID:27818126 PPARG Human metconazole multiple interactions ISO Pparg (Mus musculus) 6480464 metconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human metconazole multiple interactions EXP 6480464 metconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human metformin decreases expression EXP 6480464 Metformin results in decreased expression of PPARG mRNA CTD PMID:20956498 PPARG Human metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[cyhalothrin co-treated with Oleic Acid] results in increased expression of PPARG protein] and Metformin inhibits the reaction [INS protein results in increased expression of PPARG protein] CTD PMID:36529352 and PMID:36764371 PPARG Human metformin multiple interactions ISO Pparg (Mus musculus) 6480464 Metformin inhibits the reaction [IL13 protein results in increased expression of PPARG mRNA] CTD PMID:26497364 PPARG Human metformin affects activity ISO Pparg (Rattus norvegicus) 6480464 Metformin affects the activity of PPARG protein CTD PMID:25596134 PPARG Human metformin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Metformin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein] and Metformin inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 and PMID:30256492 PPARG Human metformin increases expression ISO Pparg (Mus musculus) 6480464 Metformin results in increased expression of PPARG mRNA CTD PMID:21870829 PPARG Human metformin increases expression ISO Pparg (Rattus norvegicus) 6480464 Metformin results in increased expression of PPARG mRNA CTD PMID:20724125 PPARG Human methamphetamine multiple interactions ISO Pparg (Mus musculus) 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [PPARG protein results in increased susceptibility to Methamphetamine] more ... CTD PMID:17019405 and PMID:18946735 PPARG Human methamphetamine increases response to substance ISO Pparg (Mus musculus) 6480464 PPARG protein results in increased susceptibility to Methamphetamine CTD PMID:17019405 PPARG Human methamphetamine increases activity ISO Pparg (Mus musculus) 6480464 Methamphetamine results in increased activity of PPARG protein CTD PMID:17019405 PPARG Human methamphetamine increases expression ISO Pparg (Mus musculus) 6480464 Methamphetamine results in increased expression of PPARG protein CTD PMID:17019405 PPARG Human methamphetamine decreases expression ISO Pparg (Mus musculus) 6480464 Methamphetamine results in decreased expression of PPARG protein CTD PMID:18946735 PPARG Human methotrexate multiple interactions ISO Pparg (Rattus norvegicus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA] more ... CTD PMID:25187349 more ... PPARG Human methotrexate decreases expression ISO Pparg (Rattus norvegicus) 6480464 Methotrexate results in decreased expression of PPARG mRNA and Methotrexate results in decreased expression of PPARG protein CTD PMID:28414158 more ... PPARG Human methotrexate increases expression ISO Pparg (Rattus norvegicus) 6480464 Methotrexate results in increased expression of PPARG protein CTD PMID:25187349 PPARG Human methyl beta-cyclodextrin multiple interactions ISO Pparg (Mus musculus) 6480464 methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]] CTD PMID:16971554 PPARG Human methyl laurate multiple interactions EXP 6480464 lauric acid methyl ester binds to and results in decreased activity of PPARG protein CTD PMID:27633901 PPARG Human methyl oleate multiple interactions EXP 6480464 methyl oleate binds to and results in increased activity of PPARG protein CTD PMID:27633901 PPARG Human methylglyoxal multiple interactions ISO Pparg (Rattus norvegicus) 6480464 PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1 more ... CTD PMID:23954466 PPARG Human methylisothiazolinone increases expression EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of PPARG mRNA CTD PMID:31629900 PPARG Human methylparaben multiple interactions ISO Pparg (Mus musculus) 6480464 PPARG protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA] CTD PMID:28527915 PPARG Human methylparaben increases response to substance ISO Pparg (Mus musculus) 6480464 PPARG protein results in increased susceptibility to methylparaben CTD PMID:28527915 PPARG Human methylparaben multiple interactions EXP 6480464 methylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 PPARG Human metolachlor multiple interactions ISO Pparg (Mus musculus) 6480464 metolachlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human metolachlor multiple interactions EXP 6480464 metolachlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human mevalonic acid multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] CTD PMID:20578043 PPARG Human mifepristone multiple interactions ISO Pparg (Mus musculus) 6480464 Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] and Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA] CTD PMID:22956630 and PMID:27145005 PPARG Human mifepristone multiple interactions ISO Pparg (Rattus norvegicus) 6480464 Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein] CTD PMID:30229846 PPARG Human mifepristone decreases expression ISO Pparg (Rattus norvegicus) 6480464 Mifepristone results in decreased expression of PPARG mRNA CTD PMID:25972201 PPARG Human miquelianin increases expression EXP 6480464 quercetin 3-O-glucuronide results in increased expression of PPARG mRNA CTD PMID:25765892 PPARG Human Mitotane multiple interactions ISO Pparg (Mus musculus) 6480464 Mitotane binds to and results in increased activity of PPARG protein CTD PMID:33049310 PPARG Human MK-2206 multiple interactions ISO Pparg (Mus musculus) 6480464 MK 2206 inhibits the reaction [Endrin results in increased expression of PPARG mRNA] CTD PMID:34801515 PPARG Human monascin multiple interactions ISO Pparg (Rattus norvegicus) 6480464 PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1 more ... CTD PMID:23954466 PPARG Human monascin increases expression EXP 6480464 monascin results in increased expression of PPARG protein CTD PMID:22381257 PPARG Human monascin decreases phosphorylation EXP 6480464 monascin results in decreased phosphorylation of PPARG protein CTD PMID:22381257 PPARG Human monascin affects localization EXP 6480464 monascin affects the localization of PPARG protein CTD PMID:23954466 PPARG Human monascin increases response to substance ISO Pparg (Rattus norvegicus) 6480464 PPARG protein results in increased susceptibility to monascin CTD PMID:23954466 PPARG Human mono(2-ethyl-5-oxohexyl) phthalate multiple interactions EXP 6480464 [Diethylhexyl Phthalate results in increased abundance of mono(2-ethyl-5-oxohexyl)phthalate] which results in decreased methylation of PPARG promoter more ... CTD PMID:30085373 and PMID:37093692 PPARG Human mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 2 more ... CTD PMID:12927354 more ... PPARG Human mono(2-ethylhexyl) phthalate affects activity EXP 6480464 mono-(2-ethylhexyl)phthalate affects the activity of PPARG protein CTD PMID:30810372 PPARG Human mono(2-ethylhexyl) phthalate multiple interactions ISO Pparg (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA and mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein CTD PMID:31884101 and PMID:33049310 PPARG Human mono(2-ethylhexyl) phthalate affects expression EXP 6480464 mono-(2-ethylhexyl)phthalate affects the expression of PPARG mRNA CTD PMID:30810372 PPARG Human mono(2-ethylhexyl) phthalate increases activity EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein CTD PMID:10581215 more ... PPARG Human mono(2-ethylhexyl) phthalate decreases expression ISO Pparg (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA CTD PMID:25543134 PPARG Human mono(2-ethylhexyl) phthalate affects binding EXP 6480464 mono-(2-ethylhexyl)phthalate binds to PPARG protein CTD PMID:23843199 and PMID:35019730 PPARG Human mono(2-ethylhexyl) phthalate increases activity ISO Pparg (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate analog results in increased activity of PPARG protein and mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein CTD PMID:10581215 more ... PPARG Human mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA and mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG protein CTD PMID:23118965 and PMID:38048874 PPARG Human mono(2-ethylhexyl) phthalate increases expression ISO Pparg (Rattus norvegicus) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PPARG mRNA and mono-(2-ethylhexyl)phthalate results in increased expression of PPARG protein CTD PMID:15647598 PPARG Human mono(5-carboxy-2-ethylpentyl) phthalate multiple interactions EXP 6480464 [Diethylhexyl Phthalate results in increased abundance of 2-ethyl-5-carboxypentyl phthalate] which results in decreased methylation of PPARG promoter CTD PMID:37093692 PPARG Human monobenzyl phthalate affects binding EXP 6480464 mono-benzyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human monobenzyl phthalate multiple interactions ISO Pparg (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA CTD PMID:31884101 PPARG Human monobenzyl phthalate increases expression EXP 6480464 mono-benzyl phthalate results in increased expression of PPARG protein CTD PMID:29089286 PPARG Human monobenzyl phthalate increases activity EXP 6480464 mono-benzyl phthalate results in increased activity of PPARG protein CTD PMID:27551952 PPARG Human Monobutylphthalate affects binding EXP 6480464 monobutyl phthalate binds to PPARG protein CTD PMID:23843199 PPARG Human Monobutylphthalate affects localization ISO Pparg (Mus musculus) 6480464 monobutyl phthalate affects the localization of PPARG protein CTD PMID:36736749 PPARG Human Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of PPARG protein CTD PMID:38048874 PPARG Human Monobutylphthalate affects expression EXP 6480464 monobutyl phthalate affects the expression of PPARG mRNA CTD PMID:28381288 PPARG Human Monobutylphthalate increases expression EXP 6480464 monobutyl phthalate results in increased expression of PPARG protein CTD PMID:29089286 PPARG Human Monobutylphthalate multiple interactions EXP 6480464 monobutyl phthalate inhibits the reaction [ciglitazone binds to and results in increased activity of PPARG protein] CTD PMID:16326050 PPARG Human monocrotophos increase 
